0001144204-16-134226.txt : 20161114 0001144204-16-134226.hdr.sgml : 20161111 20161114162843 ACCESSION NUMBER: 0001144204-16-134226 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AUDIOEYE INC CENTRAL INDEX KEY: 0001362190 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-177463 FILM NUMBER: 161995140 BUSINESS ADDRESS: STREET 1: 5210 E. WILLIAMS CIRCLE STREET 2: SUITE 750 CITY: TUCSON STATE: AZ ZIP: 85711 BUSINESS PHONE: 866-331-5324 MAIL ADDRESS: STREET 1: 5210 E. WILLIAMS CIRCLE STREET 2: SUITE 750 CITY: TUCSON STATE: AZ ZIP: 85711 10-Q 1 v451978_10q.htm 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2016

 

oTRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from [                     ] to [                     ]

 

Commission file number 333-177463 

AudioEye, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   20-2939845
(State or other jurisdiction of incorporation or
organization)
  (I.R.S. Employer Identification No.)
     
5210 East Williams Circle, Suite 750,
Tucson, Arizona
  85711
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:  866-331-5324

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the last 90 days. Yes x     No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x     No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer   ¨   Accelerated filer ¨  
             
  Non-accelerated filer ¨    Smaller reporting company   x  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o     No x

 

As of November 14, 2016, 107,500,096 shares of the registrant’s common stock were issued and outstanding.

 

 

 

 

TABLE OF CONTENTS

 

    Page
     
PART I FINANCIAL INFORMATION  
     
Item 1. Financial Statements 1
     
  Consolidated Balance Sheets as of September 30, 2016 and December 31, 2015 (unaudited) 2
     
  Consolidated Statements of Operations for the three and nine months ended September 30, 2016 and 2015 (unaudited) 3
     
  Consolidated Statement of Stockholders’ Equity for the nine months ended September 30, 2016 (unaudited) 4
     
  Consolidated Statements of Cash Flows for the nine months ended September 30, 2016 and 2015 (unaudited) 5
     
  Notes to Consolidated Financial Statements (unaudited) 6
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 24
     
Item 4. Controls and Procedures 24
     
PART II OTHER INFORMATION  
     
Item 1. Legal Proceedings 25
     
Item 1A. Risk Factors 26
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 26
     
Item 3. Defaults Upon Senior Securities 26
     
Item 4. Mine Safety Disclosures 26
     
Item 5. Other Information 26
     
Item 6. Exhibits 26
     
SIGNATURES 27

 

 

 

 

PART I — FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

The financial information set forth below with respect to the financial statements as of September 30, 2016 and 2015 and for the three and nine month periods ended September 30, 2016 and 2015 is unaudited. This financial information, in the opinion of our management, includes all adjustments consisting of normal recurring entries necessary for the fair presentation of such data. The results of operations for the three and nine month periods ended September 30, 2016 are not necessarily indicative of results to be expected for any subsequent period. Our fiscal year end is December 31.

 

1 

 

 

AUDIOEYE, INC.

CONSOLIDATED BALANCE SHEETS

(unaudited)

 

   September 30,   December 31, 
   2016   2015 
ASSETS          
Current assets:          
Cash  $1,494,513   $1,687,257 
Accounts receivable, net   20,499    22,741 
Marketable securities, held in related party   3,600    3,600 
Non-marketable securities, held in related party   50,000    50,000 
Prepaid expenses and other current assets   57,828    41,388 
Total current assets   1,626,440    1,804,986 
           
Intangible assets, net   2,454,162    2,840,856 
Goodwill   700,528    700,528 
           
Total assets  $4,781,130   $5,346,370 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current liabilities:          
Accounts payable and accrued expenses  $267,377   $213,620 
Notes and loans payable, current   24,000    24,000 
Related party payables   14,744    153,474 
Derivative liabilities   3,648,243    439,361 
Deferred revenue   414,082    60,790 
Total current liabilities   4,368,446    891,245 
           
Long term liabilities:          
Convertible notes and loans payable, net   5,800    1,923,499 
           
Total liabilities   4,374,246    2,814,744 
           
Stockholders' equity:          
Preferred stock, $0.00001 par value, 10,000,000 shares authorized, 160,000 and 175,000 issued and outstanding as of September 30, 2016 and December 31, 2015, respectively   2    2 
Common stock, $0.00001 par value, 250,000,000 shares authorized, 107,458,430 and 81,717,154 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively   1,074    817 
Treasury stock   (623,000)   (623,000)
Additional paid-in capital   33,997,819    27,393,238 
Accumulated deficit   (32,969,011)   (24,239,431)
Total stockholders' equity   406,884    2,531,626 
           
Total liabilities and stockholders' equity  $4,781,130   $5,346,370 

 

See Notes to Unaudited Consolidated Financial Statements

 

2 

 

  

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

   Three months ended September 30,   Nine months ended September 30, 
   2016   2015   2016   2015 
Revenues  $282,676   $108,685   $594,237   $314,146 
                     
Cost of revenue   311,519    321,755    904,091    1,178,388 
                     
Gross Loss   (28,843)   (213,070)   (309,854)   (864,242)
                     
Operating expenses:                    
Selling and marketing   192,881    171,594    510,448    747,990 
Research and development   85,192    92,857    255,805    293,877 
General and administrative   602,041    (27,278)   1,894,964    4,161,269 
Amortization and depreciation   150,328    128,381    428,701    396,269 
Total operating expenses   1,030,442    365,554    3,089,918    5,599,405 
                     
Operating loss   (1,059,285)   (578,624)   (3,399,772)   (6,463,647)
                     
Other income (expense):                    
Unrealized gain (loss) on derivative liabilities   351,055    -    (2,990,096)   - 
Unrealized gain on marketable securities   900    -    -    - 
Loss on settlement of debt   -    -    (1,664,281)   - 
Other income   -    -    750    - 
Interest income (expense)   266    81    (676,181)   3,345 
Total other income (expense)   352,221    81    (5,329,808)   3,345 
                     
Net loss   (707,064)   (578,543)   (8,729,580)   (6,460,302)
                     
Preferred stock dividend   (20,000)   -    (60,000)   (594,641)
                     
Net loss available to common stockholders  $(727,064)  $(578,543)  $(8,789,580)  $(7,054,943)
                     
Net loss per common share-basic and diluted  $(0.01)  $(0.01)  $(0.09)  $(0.09)
                     
Weighted average common shares outstanding-basic and diluted   107,382,344    81,800,488    95,840,596    80,007,507 

 

See Notes to Unaudited Consolidated Financial Statements

 

3 

 

 

AUDIOEYE, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2016

(unaudited)

 

                       Non-controlling         
                   Additional   Interest/         
   Common stock   Preferred stock   Paid in   Treasury   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Stock   Deficit   Total 
Balance, December 31, 2015   81,717,154   $817    175,000   $2   $27,393,238   $(623,000)  $(24,239,431)  $2,531,626 
Common stock issued for services   291,666    3    -    -    47,455    -    -    47,458 
Common stock issued in settlement of convertible notes and accrued interest   12,834,800    128    -    -    1,077,995    -    -    1,078,123 
Common stock and warrants issued for cash, net of placement costs of $60,918   11,714,285    117    -    -    1,578,965    -    -    1,579,082 
Common stock issued upon conversion of preferred stock   900,525    9    (15,000)   -    (9)   -    -    - 
Fair value of warrants issued in settlement of convertible debt and accrued interest   -    -    -    -    3,205,959    -    -    3,205,959 
Reclassify fair value of liability warrants issued in connection with sale of common stock   -    -    -    -    (218,786)   -    -    (218,786)
Warrants and Options issued for services   -    -    -    -    913,002    -    -    913,002 
Net loss   -    -    -    -    -    -    (8,729,580)   (8,729,580)
Balance, September 30, 2016   107,458,430   $1,074    160,000   $2   $33,997,819   $(623,000)  $(32,969,011)  $406,884 

 

See Notes to Unaudited Consolidated Financial Statements

 

4 

 

 

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

   Nine months ended September 30, 
   2016   2015 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(8,729,580)  $(6,460,302)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   428,701    396,269 
Amortization of debt discounts   600,301    - 
Option, warrant and PSU expense   913,002    1,200,459 
Stock issued or issuable for services   47,458    679,972 
Loss on change in derivative liabilities   2,990,096    - 
Loss on settlement of debt   1,664,281    - 
Changes in operating assets and liabilities:          
Accounts receivable   2,242    212,662 
Related party receivable   -    (44,250)
Other current assets   (16,440)   11,650 
Accounts payable and accruals   173,558    (517,743)
Billing in excess of costs   -    (57,012)
Deferred revenue   353,292    - 
Related party payables   (138,730)   (226,483)
Net cash (used in) operating activities   (1,711,819)   (4,804,778)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Cash (paid for) intellectual property   (42,007)   (88,156)
Net cash (used in) investing activities   (42,007)   (88,156)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Issuance of common stock and warrants for cash   1,579,082    325,000 
Collection of stock subscription receivable   -    1,175,000 
Issuance of preferred stock for cash   -    1,750,000 
Proceeds from exercise of options and warrants   -    43,943 
Repayments of notes payable   (18,000)   (22,000)
Net cash provided by financing activities   1,561,082    3,271,943 
           
Net decrease in cash   (192,744)   (1,620,991)
Cash-beginning of period   1,687,257    1,672,901 
Cash-end of period  $1,494,513   $51,910 
           
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION          
Interest paid  $-   $307 
Income taxes paid   -    - 
           
Non-cash investing and financing activities:          
Deemed dividend beneficial conversion feature on convertible preferred stock  $-   $594,641 
Common stock issued in settlement of convertible notes payable and accrued interest   1,078,123    - 
Fair value of warrants issued in settlement of convertible notes payable and accrued interest   3,205,959    - 
Reclass fair value of liability warrants from equity to liability upon issuance   218,786    - 
Common stock issued upon conversion of preferred stock   9    - 

 

See Notes to Unaudited Consolidated Financial Statements

 

5 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION

 

The accompanying unaudited interim financial statements of AudioEye, Inc. and its wholly-owned subsidiary (collectively, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2016.

 

In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended December 31, 2015 as reported in the Company’s Annual Report on Form 10-K have been omitted.

 

Corporate Information and Background

 

AudioEye, Inc. was formed as a Delaware corporation on May 20, 2005. The Company focuses on providing its customers with the most complete and inclusive web accessibility solution available. The Company’s suite of technologies allows its customers to provide their site visitors with an enhanced web experience. When implemented, the Company believes its solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty. In addition, the Company’s solutions provide organizations with the ability to comply with internationally accepted web content accessibility guidelines (WCAG) as well as United States, Canadian and United Kingdom accessibility laws.

 

Reclassification

 

Certain prior year amounts have been reclassified to conform to the current year presentation.

 

Revenue Recognition

 

Revenue is recognized when all applicable recognition criteria have been met, which generally include (a) persuasive evidence of an existing arrangement; (b) fixed or determinable price; (c) delivery has occurred or service has been rendered; and (d) collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a) estimate of total hours and milestones to complete; (b) total hours completed; (c) delivery of services rendered; (d) change in estimates; and (e) collectability of the contract.

 

The Company had one major customer including their affiliates which generated approximately 55% of its revenue in the three months ended September 30, 2016.

 

The Company had four major customers including their affiliates which generated approximately 43% (21%, 16%, 15% and 11%) of its revenue in the nine months ended September 30, 2016.

 

At September 30, 2016, the Company had three customers representing 24%, 17% and 15% of the outstanding accounts receivable.

 

Certain Software as a Service (SaaS) and website hosting contracts are prepared and invoiced on an annual basis. Any funds received for hosting services not provided yet are held in deferred revenue, and are recorded as revenue when earned.

 

6 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.

 

Stock based compensation

 

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash.

 

Derivative Instrument Liability

 

The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At September 30, 2016 and December 31, 2015, the Company did not have any derivative instruments that were designated as hedges.

 

On October 9, 2015, the Company issued convertible promissory notes representing $2,500,000 in aggregate principal together with warrants exercisable for up to 25,000,000 shares of Common Stock. The warrants have a strike price of $0.10 and term of 5 years. In addition on May 9, 2016, in connection with the sale of the Company’s common stock, the Company issued warrants exercisable for up to 1,312,000 shares of Common Stock. The warrants have a strike price of $0.25 and a term of 5 years.

 

In accordance with ASC 815, these outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheets. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the “operating activities” of the Consolidated Statements of Cash Flow. At September 30, 2016 and December 31, 2015, the derivative liability was stated at $3,648,243 and $439,361, respectively. The change in fair value of $2,990,096 was driven by the increased value of the Company’s common stock in the period and recorded as the “Loss on change in derivative liability” in the Consolidated Statements of Operations for the nine months ended September 30, 2016. As the warrants are exercised or expire, the derivative liability will be adjusted on the balance sheet and an adjustment will be reflected in stockholders equity under additional paid-in capital.

 

7 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

Fair Value Measurements

 

Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels: 

 

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.

 

Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.

 

Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.

 

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

 

In October and November 2015, the Company issued warrants with an exercise price of $0.10 in connection with a convertible debt instruments. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.10 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.

 

The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.031 to $0.058, volatility was estimated to be 102%, the risk free rate ranged 1.14% to 1.75% and the remaining term was 5 years.

 

In April and May 2016, the Company issued warrants with an exercise price of $0.25 in connection with the sale of Common Stock. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.25 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.

 

The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.169 to $0.195, volatility was estimated to be from 169% to 178%, the risk free rate ranged 1.22% to 1.35% and the remaining term was 5 years. The estimated initial fair value of these warrants of $218,786 was reclassified from equity to liability at the date of issuance.

 

8 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

At September 30, 2016, the price of the Company stock was 0.149, volatility was estimated to be 170.52%, the risk free rate of 1.14% and the remaining term ranged from 4.02 to 4.56 years. As of September 30, 2016, the fair value of the warrants was determined to be $3,648,243, resulting in an unrealized gain (loss) on the change in the fair value of this derivative liability of $351,055 and $(2,990,096) for the three and nine months ended September 30, 2016, respectively.

 

The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of September 30, 2016 and December 31, 2015:

 

       Fair Value
   Fair Value   Hierarchy
Assets        
Marketable securities, September 30, 2016  $3,600   Level 1
Marketable securities, December 31, 2015  $3,600   Level 1
         
Liabilities        
Derivative Liability , September 30, 2016  $3,648,243   Level 3
Derivative Liability , December 31, 2015  $439,361   Level 3

 

Recent Accounting Pronouncements

 

There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.

 

NOTE 2: MANAGEMENT LIQUIDITY PLANS

 

As of September 30, 2016, the Company had cash of $1,494,513 and working capital deficit of $2,742,006, principally due to the inclusion of non-cash derivative liability recorded in current liabilities. Excluding the derivative liability, the Company’s working capital would have been $906,237. In addition, the Company used actual net cash in operations of $1,711,819 during the nine months ended September 30, 2016. The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

  

In May 2016, the Company sold shares of common stock and warrants for net proceeds, after commissions and other costs, of approximately $1,579,082.  It is anticipated that the proceeds from the sale of its common stock and warrants will provide the Company with cash sufficient to fund operations through May 2017. 

 

The Company expects that cash used in operations will decrease significantly over the next several years as the Company executes its business plan. In the event that the Company is not able to fully achieve its plan, the Company may need to raise additional funds through equity or debt financing. If the Company is unsuccessful in raising additional financing, it will need to reduce costs and operations in the future.

 

Accordingly, the accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.

 

9 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

NOTE 3: RELATED PARTY TRANSACTIONS

 

Dr. Carr Bettis, Executive Chairman and Chairman of Board of Directors

 

As of September 30, 2016 and December 31, 2015, the Company owed Dr. Bettis $5,992 and $72,944 in accrued salary, respectively. In addition, AudioEye sub-leases an office for the Company’s CEO Todd Bankofier from Verus Analytics, Inc, a company in which Dr. Bettis has a controlling interest in. The sub-lease amount is $500 per month totaling $1,500 and $4,500 in three and nine months ended September 30, 2016.

 

Sean Bradley, President, Chief Technology Officer, and Secretary

 

As of September 30, 2016 and December 31, 2015, the Company owed Sean Bradley $8,752 and $6,250 in accrued salary, respectively.

 

David Moradi, a Material Shareholder, on a fully diluted basis

 

As of December 31, 2015 the Company owed David Moradi $70,000 in principal and $4,280 in accrued interest. During the nine months ended September 30, 2016, Mr. Moradi was paid in full. As of September 30, 2016, Mr. Moradi is no longer considered a material shareholder.

 

In summary, as of September 30, 2016 and December 31, 2015 the total balances of related party payables were $14,744 and $153,474, respectively.

 

NOTE 4: INTANGIBLE ASSETS

 

For the nine months ended September 30, 2016 and 2015, the Company invested in Patents in the amounts of $42,007 and $88,156 respectively.

 

Prior to December 31, 2015, patents, technology and other intangibles with contractual terms were generally amortized over their estimated useful lives of ten years. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted.

 

Software development costs are amortized over their estimated useful life of three years.

 

Prior to any impairment adjustment, intangible assets consisted of the following:

 

   September 30,   December 31, 
   2016   2015 
Patents  $3,697,076   $3,655,069 
Capitalized software development   621,567    621,567 
Accumulated amortization   (1,864,481)   (1,435,780)
Intangible assets, net  $2,454,162   $2,840,856 

 

Amortization expense for patents totaled $94,209 and $281,064 for the three and nine months ended September 30, 2016, respectively; and $87,395 and $268,940 for the three and nine months ended September 30, 2015, respectively. Amortization expense for software development totaled $56,119 and $147,637 for the three and nine months ended September 30, 2016, respectively; and $40,427 and $126,677 for the three and nine months ended September 30, 2015, respectively.

 

Total amortization expense totaled $428,701 and $395,617 for the nine months ended September 30, 2016 and 2015, respectively.

 

10 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

NOTE 5: NOTES PAYABLE

 

As of September 30, 2016 and December 31, 2015, the Company has short term and long term notes payable of $24,000 and $5,800, and $24,000 and $1,923,499, respectively as shown in the table below.

 

Notes and loans payable  September 30,
2016
   December 31,
2015
 
Short Term          
Maryland TEDCO  $24,000   $24,000 
Total  $24,000   $24,000 
Long Term          
Convertible Secured Note (net of unamortized discounts of $600,301 in 2015)   -    1,899,699 
Maryland TEDCO  $5,800   $23,800 
Total  $5,800   $1,923,499 

 

As of December 31, 2012, the Company had an outstanding loan to a third party in the amount of $74,900, which was originally issued during 2006 as part of an Investment Agreement. The loan was unsecured and bore interest at 25% per year for four years. The Company had accrued interest of $74,900, which was included in accounts payable and accrued expenses on the consolidated balance sheets.  The note was in default until October 24, 2011, at which time the Company entered into a Termination and Release Agreement (“Release”) with the third party.  The terms of the Release, among other things, terminated the Investment Agreement between the parties, and required the Company to issue a Promissory Note to the third-party in the combined amount of principal and accrued interest to date, for a total principal amount of $149,800.  The note is interest free, and is payable in monthly installments of $2,000 beginning November 1, 2011.  As of September 30, 2016 and December 31, 2015, the principal amount owing was $29,800 and $47,800, respectively, of which $24,000 and $24,000, respectively, has been recorded as the current portion of the note, and $5,800 and $23,800, respectively, as the long-term portion of the note. The Company has paid $18,000 for the nine months ended September 30, 2016.

 

On October 9, 2015 (the “Initial Closing Date”), AudioEye, Inc. (the “Company”) entered into a Note and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”) for the issuance and sale of convertible promissory notes in an aggregate principal amount of up to $3,750,000 (the “Notes”) and warrants (the “Warrants”) to purchase up to an aggregate of 37,500,000 shares of common stock of the Company (the “Common Stock”) (the “Transaction”). Notes representing up to $2,500,000 in aggregate principal, and Warrants exercisable for up to 25,000,000 shares of Common Stock in the aggregate, may be issued and sold at one or more closings during the 30-day period immediately following the Initial Closing Date. The maximum of $2,500,000 in aggregate principal was sold as of November 8, 2015. In addition, upon the election of any Investor within the three-year period immediately following the Initial Closing Date, any Investor may purchase an additional Note in the principal amount equal to 50% of the principal amount of the Notes purchased by such Investor at previous closings (the “Option Principal Amount”) and an additional Warrant with an aggregate exercise price equal to such Investor’s Option Principal Amount.

 

The Notes mature three years from the date of issuance (the “Maturity Date”) and, until the Notes are repaid or converted into shares of the Company’s equity securities (“Equity Securities”), accrue payable-in-kind interest at the rate of 10% per annum. As described in the Purchase Agreement, as amended (see below), if the Company sold Equity Securities in a single transaction or series of related transactions for cash of at least $1,000,000 (excluding the conversion of the Notes and excluding the shares of Common Stock to be issued upon exercise of the Warrants) on or before the Maturity Date (the “Equity Financing”), all of the unpaid principal on the Notes plus accrued interest shall be automatically converted at the closing of the Equity Financing into a number of shares of the same class or series of Equity Securities as are issued and sold by the Company in such Equity Financing (or a class or series of Equity Securities identical in all respects to and ranking pari passu with the class or series of Equity Securities issued and sold in such Equity Financing) as is determined by dividing (i) the principal and accrued and unpaid interest amount of the Notes by (ii) 60% of the price per share at which such Equity Securities are issued and sold in such Equity Financing. The Notes, if not converted, shall be due and payable in full on the Maturity Date.

 

11 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

The Notes contained customary events of default provisions. In connection with the issuance of the Notes, on October 9, 2015, the Company entered into a Security Agreement with the Investors (the “Security Agreement”) pursuant to which the Company granted a security interest in all of its assets to the Investors as collateral for the Company’s obligations under the Notes. As noted below, on April 18, 2016, the parties agreed to remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement.

 

The Warrants are exercisable at $0.10 per share and expire 60 months following the date of issuance. The Warrants are subject to anti-dilution protection, subject to certain customary exceptions.

 

During 2015, the Company issued notes under this offering totaling $2,500,000. The fair value of the warrants issued in connection with the notes was determined to be $627,293 and was recognized as a discount to the debt being amortized to interest expense over the life of the loans. During three and nine months ended September 30, 2016, aggregate amortization (and write-off) of $-0- and $600,301 was recognized against the discount.

 

In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the “Purchase Agreement Amendment”) and an Omnibus Amendment to Secured Promissory Notes (the “Note Amendment”), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the “Original Agreement”) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, “Anthion”) to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of “qualified financing” under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing “blocker” provisions (“Special Warrants”) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar “blocker” provisions.

 

On April 18, 2016, the Company issued an aggregate of 12,834,800 shares of its common stock to the Note holders other than Anthion, and 18,353,310 warrants to acquire its common stock to Anthion in lieu of common stock. Collectively the common stock and warrants issued were in full settlement of $2,500,000 convertible notes and accrued interest of $119,801. The warrants issued to Anthion are exercisable at $0.001 per share for five years from the date of issuance.

 

At the date of conversion, the Company determined that the conversion price of $0.84 per share did not exceed the fair value of Common Stock at note inception, therefore there was no beneficial conversion feature upon conversion of $1,025,000 of convertible notes and accrued interest. However, the Company determined that the estimated fair value of the 18,353,310 warrants of $3,205,959 exceeded the settlement of $1,541,678 of convertible notes and accrued interest and accordingly recorded a loss of settlement of debt of $1,664,281 for the nine months ended September 30, 2016. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the warrants at the date of conversion using the following assumptions: the price of the Company stock of $0.175, volatility was estimated to be 178%, the risk free rate of 1.24% and the remaining term was 5 years.

 

NOTE 6: STOCKHOLDERS’ EQUITY

 

As of September 30, 2016 and December 31, 2015, the Company had 107,458,430 and 81,717,154 shares of common stock issued and outstanding, respectively, and the Company had 160,000 and 175,000 shares of Series A Convertible Preferred Stock, respectively, issued at $10 per share, paying a 5% cumulative annual dividend and convertible at 0.1754 per share of common stock.

 

12 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

In April 2016, the Company issued an aggregate 83,336 shares of its common stock in payment for consulting services at a fair value of $14,292.

 

In April 2016, the Company issued an aggregate of 12,834,800 shares of its common stock to Note holders in settlement of $1,025,000 in convertible notes and accrued interest (Note 5).

 

In May 2016, the Company sold an aggregate of 11,714,285 shares of common stock of the Company and 1,312,000 warrants to purchase the Company’s common stock to accredited investors for net proceeds of $1,579,082.  The warrants have a term of five years, an exercise price of $0.25 per share and are subject to anti-dilution protection, as defined.

 

In May 2016, the Company issued 900,525 shares of its common stock upon conversion of 15,000 shares of Series A Convertible Preferred Stock and accrued dividends.

 

In July 2016, the Company issued an aggregate 124,998 shares of its common stock in payment for consulting services at a fair value of $20,666.

 

In August 2016, the Company issued an aggregate 41,666 shares of its common stock in payment for consulting services at a fair value of $6,208.

 

In September 2016, the Company issued an aggregate 41,666 shares of its common stock in payment for consulting services at a fair value of $6,292.

 

Registration rights

 

Under the purchase agreement, the Company has agreed to use its reasonable best efforts to prepare and file with the SEC registration statement within 60 days of the initial closing date, covering the resale by the investors of any common stock previously issued to the investors, and any common stock into which any convertible promissory notes previously issued to the investors are convertible and any common stock for which the warrants or any warrants previously issued to the investors are exercisable. The Company filed a registration statement on September 30, 2016. 

 

NOTE 7: OPTIONS

 

As of September 30, 2016 and December 31, 2015, the Company has outstanding options to purchase 25,005,504 and 14,759,914 shares of common stock, respectively.

 

                   Intrinsic 
           Wtd Avg.       Value 
   Number of   Wtd Avg.   Remaining       of Exercisable 
   Options   Exercise Price   Term   Exercisable   Options 
Outstanding at December 31, 2015   14,759,914   $0.30    3.61    8,374,294   $ 
                          
Granted   10,756,090    0.08    4.86          
Forfeited/Expired   (510,500)   0.78               
                          
Outstanding at September 30, 2016   25,005,504   $0.20    3.52    13,177,211   $417,857 

 

13 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

On January 15, 2016, the Company granted performance options to acquire shares of the Company’s common stock in aggregate of 6,500,000 to key board member and officers at an exercise price of $0.038 per share for five years. Vesting shall only occur if the closing share price of the Company’s common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition). Of the granted options, 5,500,000 include performance conditions (as defined) with both conditions (market and performance) to be met before vesting. All determinations of whether performance goals have been achieved, the number of vested performance options earned by the grantee, and all other matters related to the award of performance options shall be made by the compensation committee of the Company’s board of directors in its sole discretion.

 

The estimated fair values of the options with performance and market conditions were determined using a Monte Carlo pricing model. Significant assumptions used in the valuation include expected term of 5 years, expected volatility of 162%, risk free interest rate of 1.46%, and expected dividend yield of 0%.

 

Nonperformance option grants during the nine months ended September 30, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 to 3.5 years, expected volatility of 102.00% to 174.99%, risk free interest rate of 0.87% to 1.73%, and expected dividend yield of 0%.

 

On April 15, 2016, the Company issued 49,715 options, which vest immediately, have an exercise price of $0.179, and expire on April 15, 2019. The value on the grant date of the options was $6,250.

 

On May 12, 2016, the Company issued 100,000 options, which vest 50% after one year and 4.17% every month thereafter, have an exercise price of $0.177, and expire on May 12, 2021. The value on the grant date of the options was $16,694.

 

On May 12, 2016, the Company issued an aggregate of 3,400,000 options, which vest 50% immediately and 50% vesting quarterly over 12 months, have an exercise price of $0.177, and expire on May 12, 2021. The value on the grant date of the options was $559,603.

 

On July 15, 2016, the Company issued 56,375 options, which vest immediately, have an exercise price of $0.156, and expire on July 15, 2019. The value on the grant date of the options was $6,250.

 

For the three and nine months ended September 30, 2016 and 2015, total stock compensation expense related to the options totaled $166,111 and $706,230 and $(119,224) and $709,311, respectively.

 

NOTE 8: WARRANTS

 

Below is a table summarizing the Company’s outstanding warrants as of September 30, 2016 and December 31, 2015:

 

                   Intrinsic 
           Wtd Avg.       Value 
   Number of   Wtd Avg.   Remaining       of Exercisable 
   Warrants   Exercise Price   Term   Exercisable   Warrants 
Outstanding at December 31, 2015   42,526,609   $0.22    4.15    41,297,920   $1,167 
                          
Exercised   -                     
Granted   21,961,513    0.02    4.66         - 
Expired   (393,081)   0.42                
                          
Outstanding at September 30, 2016   64,095,041    0.15    3.73    63,907,541   $4,059,950 

 

14 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

NOTE 8: WARRANTS

 

The warrant grants during the nine months ended September 30, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 to 2.5 years, expected volatility of 166.74% to 178.98%, risk free interest rate of 0.71% to 1.08%, and expected dividend yield of 0%.

 

During the nine months ended September 30, 2016, the Company issued an aggregate of 1,575,954 warrants to purchase shares of the Company’s common stock with an exercise prices of $0.038 to $0.179 per share vested immediately for services. The fair value on the grant date of the warrants was $150,500.

 

In April 2016, the Company issued an aggregate of 18,353,310 warrants to acquire its common stock in settlement of $1,541,678 convertible notes and accrued interest. The warrants issued to Anthion are exercisable at $0.001 per share for five years from the date of issuance.

 

The Company determined that the estimated fair value of the 18,353,311 warrants of $3,205,959 exceeded the settlement of $1,541,678 of convertible notes and accrued interest and accordingly recorded a loss of settlement of debt of $1,664,281 for the nine months ended September 30, 2016. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the warrants at settlement with the following assumptions: the price of the Company stock of $0.175, volatility was estimated to be 178%, the risk free rate of 1.24% and the remaining term was 5 years.

 

In May 2016, the Company issued 1,312,000 warrants with an exercise price of $0.25 in connection with the sale of Common Stock. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.25 per share.

 

For the three and nine months ended September 30, 2016 and 2015, the Company has incurred warrant-based expense of $58,599 and $206,772 and $20,962 and $491,148, respectively. 

 

NOTE 9: COMMITMENTS AND CONTINGENCIES

 

Litigation

 

In April 2015, two shareholder class action lawsuits were filed against the Company and former officers Nathaniel Bradley and Edward O’Donnell in the U.S. District Court for the District of Arizona. The plaintiffs allege various causes of action against the defendants arising from our announcement that our previously issued financial results for the first three quarters of 2014 and the guidance for the fourth quarter of 2014 and the full year of 2014 could no longer be relied upon.  The complaints sought among other relief, compensatory damages and plaintiff’s counsel’s fees and experts’ fees. The Court appointed a lead plaintiff and lead counsel, and consolidated the actions. A consolidated amended complaint was filed under the caption In re AudioEye, Inc. Sec. Litigation. The Company and individual defendants filed a motion to dismiss. 

 

On July 25, 2016, in connection with a voluntary mediation, the parties reached an agreement in principle to settle the consolidated actions. The settlement agreement is subject to definitive documentation, shareholder notice, and court approval. The terms of the agreement include a settlement payment to the class of $1,525,000 from the Company’s insurer, with no admission of liability by any party. In 2015, the Company paid a deductible under its D&O insurance policy in the amount of $100,000 regarding this matter.

 

On May 16, 2016, a shareholder derivative complaint entitled LiPoChing, Derivatively and on Behalf of AudioEye, Inc., v. Bradley, et al., was filed in the United States District Court for the District of Arizona. As a derivative complaint, the plaintiff-shareholder purports to act on behalf of the Company against certain of the Company's current and former officers and directors (the “Named Individuals”).

 

15 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2016 (Unaudited)

 

The Company is named as a nominal defendant. The complaint asserts causes of action including breach of fiduciary duty and others, arising from the Company’s restatement of its financial results for the first three quarters of 2014. The complaint seeks, among other relief, compensatory damages, restitution and attorneys’ fees. No discovery has occurred. In October 2016, the Company and Named Defendants filed a motion to dismiss, which remains pending. While the Company believes that its legal defense costs may be reimbursed by the Company’s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement.

 

 On July 26, 2016, a shareholder derivative complaint entitled Denese M. Hebert, derivatively on Behalf of Nominal Defendant AudioEye, Inc., v. Bradley, et al., was filed in the State of Arizona Superior Court for Pima County. The complaint generally asserts causes of action related to the Company’s restatement of its financial statements for the first three fiscal quarters of 2014.  As a derivative complaint, the plaintiff-shareholder purports to act on behalf of the Company against certain of the Company's current and former officers and directors (the “Named Individuals”). The Company is named as a nominal defendant. The Company understands that the Named Individuals intend to vigorously defend the lawsuit. While the Company believes that its legal defense costs may be reimbursed by the Company’s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement.

 

We may become involved in various other routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.

 

NOTE 10: SUBSEQUENT EVENTS

 

Employee options/warrants

 

On October 15, 2016, the Company granted 61,599 options to Sean Bradley as compensation for services rendered. The options are exercisable at $0.125 for three years, vesting immediately. The exercise price was determined using the 10-day average closing price beginning with the closing price on October 1, 2016.

 

Common stock

 

In October 2015, the Company issued 41,666 shares of its common stock for consulting services rendered valued at $4,292.

 

16 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations or MD&A, should be read in conjunction with our consolidated financial statements and related notes in Part I, Item 1 of this report.

 

As used in this quarterly report, the terms “we,” “us,” “our” and similar references refer to AudioEye, Inc. and our wholly-owned subsidiary, unless otherwise indicated.

 

Cautionary Note Regarding Forward-Looking Statements

 

Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, prospects, financial condition, assumptions or future events or performance are not historical facts and are “forward-looking statements” as that term is defined under the federal securities laws. These statements are often, but not always, made through the use of words or phrases such as “believe”, “anticipate”, “should”, “intend”, “plan”, “will”, “expects”, “estimates”, “projects”, “positioned”, “strategy”, “outlook” and similar words. You should read the statements that contain these types of words carefully. Such forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from what is expressed or implied in such forward-looking statements. There may be events in the future that we are not able to predict accurately or over which we have no control. Potential risks and uncertainties include, but are not limited to, those discussed in “Part I, Item 1A. Risk Factors” in our Annual Report filed on Form 10-K for the year ended December 31, 2015. We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or uncertainties after the date hereof or to reflect the occurrence of unanticipated events.

 

Overview

 

AudioEye is a marketplace leader providing web accessibility solutions for our clients’ customers through our Ally Platform Products. Our technology advances accessibility with patented technology solutions that reduce barriers, expand access for individuals with disabilities, and enhance the user experience for a broader audience of users. When implemented, we believe that our solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty.  In addition, our solutions help organizations comply with internationally accepted Web Content Accessibility Guidelines (WCAG) as well as US, Canadian, Australian, and United Kingdom accessibility laws.

 

We generate revenues through the sale of subscriptions of our software as a service (SaaS) technology platform, called the AudioEye Ally Platform, to website owners, publishers, developers, and operators and through the delivery of managed services combined with the implementation of the AudioEye solution. Our solutions have been adopted by some of the largest and most influential companies in the world. Our customers span disparate industries and target market verticals, which encompass (but are not limited to) the following categories: human resources, finance, transportation, media, and education. Government agencies have also integrated our software in their digital platforms.

 

The AudioEye Solution

 

AudioEye uses proprietary technology and development tools to offer web accessibility solutions that offer significant savings in time and money relative to traditional solutions. Our compliance solutions focus on rapid remediation of the most important accessibility issues, followed by in-depth analysis identifying and addressing a more comprehensive compliance program. Our technology was built to not only provide users with a cloud-based assistive toolset that gets embedded and made freely available to users within our client websites, but to also improve the code in a way that optimizes the user experience for users of existing third-party assistive technologies, such as screen readers.

 

17 

 

 

Intellectual Property

 

Our technology development was initiated at the University of Arizona Science & Technology Park in Tucson, Arizona. In 2006, we received technology development venture funding from the Maryland Technology Development Corporation (TEDCO), which contributed to the development of our platform strategy. Beginning in 2009, we engaged in a multi-year technology development program with the Eller College of Management’s Department of Management Information Systems at the University of Arizona.  In connection with our proprietary technology, our company has been issued a number of U.S. patents in two distinct patent families.  Today, an experienced team of in-house engineers, designers, and developers in our Atlanta, GA, and Tucson, AZ, offices develop the Company’s technology & software and are actively engaged in the expansion of the AudioEye IP Portfolio.

 

Our patented technology was a 2013 Edison Gold Award winner for innovation in the category of “Quality of Life.”

 

Our intellectual property is primarily comprised of trade secrets, trademarks, issued and pending patents, copyrights and technological innovation. We have a patent portfolio comprised of six patents issued in the United States, we have received a notice of allowance from the U.S. Patent and Trademark Office for a seventh patent, and we have several additional patents that are either pending or are being prepared for filing in the United States and internationally.

 

Our current patented invention relates to a server-side method and apparatus that enables users to audibly navigate websites and hear high-quality streaming audio narration and descriptions of websites.  This patented invention involves creating an audio-enabled web experience by utilizing voice talent and automated text-to-speech conversion methods to read and describe web content. It involves the creation of audio files for each section within a website, and then assigning a hierarchy and navigation system in line with the website design.  To implement the system, a script is installed across the pages of the website and, when loaded, it plays an audible tone upon a user’s visit indicating that the website is enhanced with our proprietary technology.  Upon hearing the tone, a user presses a key on the keyboard to enter the audible website.  Audible narration is played through the user’s computer, reading text and describing non-text information, such as images.  The narration includes menus for navigating the site which have a hierarchy in line that of the original website.  Users navigate the website menus and move from webpage to webpage by making keystrokes or using a mouse.

 

Our current portfolio has established a foundation for building unique technology solutions that contribute to the way in which we differentiate ourselves from other competitors in the B2B Web Accessibility marketplace. We plan to continue to invest in research and development, and expand our portfolio of proprietary intellectual property.

 

Our Annual Report filed on Form 10-K for the year ended December 31, 2015 provides additional information about our business and operations.

 

Results of Operations

 

Our consolidated audited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”). The discussion of the results of our operations compares the three and nine months ended September 30, 2016 with the three and nine months ended September 30, 2015 and are not necessarily indicative of the results which may be expected for any subsequent period.  Our prospects should be considered in light of the risks, expenses and difficulties encountered by companies in similar positions.  We may not be successful in addressing these risks and difficulties.

 

18 

 

 

Comparative for the Three Months ended September 30, 2016 and September 30, 2015

 

Results of Operations

 

   Three Months Ended 
   September 30, 
   2016   2015 
Revenue   282,676   $108,685 
           
Cost of sales   311,519    321,755 
Gross loss   (28,843)   (213,070)
Operating expenses:          
Selling & marketing   192,881    171,594 
Research & development   85,192    92,857 
General and administrative expenses   602,041    (27,278)
Amortization & depreciation   150,328    128,381 
Total operating expenses   (1,030,442)   (365,554)
Operating loss   (1,059,285)   (578,624)
           
Unrealized gain on derivative liabilities   351,055    - 
Unrealized gain on marketable securities   900    - 
Interest income/(expense)   266    81 
           
Net (loss)   (707,064)   (578,543)
Deemed dividend on Series A Convertible preferred stock   (20,000)   (-)
Net loss attributable to common stockholders  $(727,064)  $(578,543)
Net loss per common share – basic and diluted   (0.01)   (0.01)
Weighted average common shares outstanding – basic and diluted   107,382,344    81,800,488 

  

Revenue

 

For the three months ended September 30, 2016 and 2015, revenue was $282,676 and $108,685, respectively, consisting primarily of revenues from various levels of licensing, website design and maintenance. Revenues increased due to a change of marketing focus.

 

Cost of Sales

 

For the three months ended September 30, 2016 and 2015, cost of sales was $311,519 and $321,755, respectively, consisting primarily of sub-contracting to outside sources, direct labor and direct technology costs.

 

Gross Loss

 

An increase in our implementation costs resulted in a gross loss of $28,843 and $213,070 during the three months ended September 30, 2016 and 2015, respectively. Gross loss decreased as a result of lower implementation costs as compared to the same period in 2015.

 

Selling and Marketing Expenses

 

Selling and marketing expenses were $192,881 and $171,594 for the three months ended September 30, 2016 and 2015, respectively.  The increase resulted from the higher sales activity in 2016 as compared to 2015.

 

19 

 

 

Research and Development Expenses

 

Research and development expenses were $85,192 and $92,857 for three months ended September 30, 2016 and 2015, respectively. Research and development expenses decreased from period to period and reflect continued developments of our product.

 

General and Administrative Expenses

 

General and administrative expenses were $602,041 and $(27,278) for the three months ended September 30, 2016 and 2015, respectively. In 2015, we recaptured stock option and warrant expense incurred in prior periods due to the forfeitures of unvested awards due to from staff reductions. Stock based compensation for the three months ended September 30, 2016 was $224,710 as compared to $(299,811) for the same period last year.

 

Amortization and Depreciation

 

Amortization and depreciation expenses were $150,328 and $128,381 for the three months ended September 30, 2016 and 2015, respectively. The increase in expense was primarily related to added patent costs in later 2015 and 2016.

 

Gain on change in Fair Value of Derivative Liabilities

 

In October 2015 and in 2016, we issued warrants with an embedded reset provisions requiring us to fair value the derivatives each reporting period and mark to market as a non-cash adjustment to our current period operations. This resulted in a gain of $351,055 on change in fair value of derivative liabilities for the three months ended September 30, 2016. None were issued as of September 30, 2015.

 

Interest Income (Expense), net

 

Interest income (expense), net during the three months ended September 30, 2016 was $266 compared to $81 three months ended September 30, 2015. Both representing interest earning with our interest bearing deposit accounts.

 

20 

 

 

Comparative for the Nine Months ended September 30, 2016 and September 30, 2015

 

Results of Operations

 

   Nine Months Ended 
   September 30, 
   2016   2015 
Revenue   594,237   $314,146 
           
Cost of sales   904,091    1,178,388 
Gross loss   (309,854)   (864,242)
Operating expenses:          
Selling & marketing   510,448    747,990 
Research & development   255,805    293,877 
General and administrative expenses   1,894,964    4,161,269 
Amortization & depreciation   428,701    396,269 
Total operating expenses   (3,089,918)   (5,599,405)
Operating loss   (3,399,772)   (6,463,647)
           
Unrealized loss on derivative liabilities   (2,990,096)   - 
Loss on settlement of debt   (1,664,281)   - 
Other income   750    - 
Interest income/(expense)   (676,181)   3,345 
           
Net (loss)   (8,729,580)   (6,460,302)
Deemed dividend on Series A Convertible preferred stock   (60,000)   (594,641)
Net loss attributable to common stockholders  $(8,789,580)  $(7,054,943)
Net loss per common share – basic and diluted   (0.09)   (0.09)
Weighted average common shares outstanding – basic and diluted   95,840,596    80,007,507 

  

Revenue

 

For the nine months ended September 30, 2016 and 2015, revenue was $594,237 and $314,146, respectively, consisting primarily of revenues from various levels of licensing, website design and maintenance. Revenues increased due to a change of marketing focus.

 

Cost of Sales

 

For the nine months ended September 30, 2016 and 2015, cost of sales was $904,091 and $1,178,388, respectively, consisting primarily of sub-contracting to outside sources, direct labor and direct technology costs.

 

Gross Loss

 

An increase in our implementation costs resulted in a gross loss of $309,854 and $864,242 during the nine months ended September 30, 2016 and 2015, respectively. Gross loss decreased as a result of lower implementation costs as compared to the same period in 2015.

 

Selling and Marketing Expenses

 

Selling and marketing expenses were $510,448 and $747,990 for the nine months ended September 30, 2016 and 2015, respectively.  The decrease resulted from the reduction primarily in staffing levels.

 

21 

 

 

Research and Development Expenses

 

Research and development expenses were $255,805 and $293,877 for nine months ended September 30, 2016 and 2015, respectively. Research and development expenses declined from period to period and reflect the material completion of our product.

 

General and Administrative Expenses

 

General and administrative expenses were $1,894,964 and $4,161,269 for the nine months ended September 30, 2016 and 2015, respectively. General and administrative expenses decreased as a result of employee staff reductions and the associated benefits costs as well as decrease in stock based compensation year over year.

 

Amortization and Depreciation

 

Amortization and depreciation expenses were $428,701 and $396,269 for the nine months ended September 30, 2016 and 2015, respectively. The increase in expense was primarily related to added patent costs in later 2015 and 2016.

 

Loss on change in Fair Value of Derivative Liabilities

 

In October 2015 and in 2016, we issued warrants with an embedded reset provisions requiring us to fair value the derivatives each reporting period and mark to market as a non-cash adjustment to our current period operations. This resulted in a loss of $2,990,096 on change in fair value of derivative liabilities for the nine months ended September 30, 2016. None were issued as of September 30, 2015.

 

Loss on settlement of Debt

 

In April 2016, we issued common stock warrants in settlement of convertible debt and accrued interest. As such, we incurred a non-cash loss on debt settlement between the estimated fair value of the issued warrants and the carrying value of the debt and accrued interest of $1,664,281.

 

Interest Income (Expense), net

 

Interest income (expense), net during the nine months ended September 30, 2016 was $(676,181) compared to $3,345 for the nine months ended September 30, 2015. For 2016, Interest expense consists of amortization of debt discounts and interest incurred relating to our issued notes payable, as compared to interest income of $3,264 for the nine months ended September 30, 2016

 

Contracts in Process/Revenue Recognition

 

Under current accounting procedures, the Company only recognizes revenue on new contracts for the actual services delivered in the period under the following criteria: i) the contract has been signed and delivered to the Company; ii) the services have been performed or delivered; and iii) the client has been billed for the services delivered. The Company does not record deferred revenues for new contracts until the first payment for services has been received. The Company only records accounts receivable for the amount of revenue recognized as service is rendered, even if the client has been billed for the entire contract value. The table below summarizes the amount of contract value in excess of the revenue recognized of $644,334 and the deferred revenue recognized of $445,082, in the amount of $318,824. This amount is expected to be recognized in future periods. The Company also receives contracts for service hours but whose total contract value is uncertain. These “fee for service contracts” are recorded in the table below only if the services have been delivered and the associated revenue has been recognized.

 

22 

 

 

A summary of our contracts in process is as follows:

 

    Contracts in Process  
    September 30, 2016  
                               
          Revenue     Revenue
Recognized
    Deferred     Contract Amount in
Excess of Deferred
 
    Contract     Recognized     9 Months Ended     Revenue     Revenue and  
    Amount     prior to 2016     September 30, 2016     September 30, 2016     Recognized Revenue  
Fixed Contracts   $ 1,330,408     $ 50,097     $ 516,405     $ 445,082     $ 318,824  
Fee for Service Contracts     77,832               77,832                  
    $ 1,408,240     $ 50,097     $ 594,237     $ 445,082     $ 318,824  

 

Liquidity and Capital Resources

 

Working Capital

 

   At September 30,   At December 31, 
   2016   2015 
Current Assets  $1,626,440   $1,804,986 
Current Liabilities   4,368,446    891,245 
Working Capital (Deficit)  $(2,742,006)  $913,741 

 

The working capital (deficit)/surplus for the periods ended September 30, 2016 and December 31, 2015 was $(2,742,006) and $913,741 respectively. The decrease in Working Capital was primarily due to an increase in our non-cash derivative liability, accounts payable, deferred revenue and decrease in cash. Adjusting for the non-cash derivative liability, Working Capital would have been $906,237 at September 30, 2016. In addition, the Company used actual net cash in operations of $1,711,819 during the nine months ended September 30, 2016. The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

 

 

The Company expects that cash used in operations will decrease significantly over the next several years as the Company executes its business plan. In the event that the Company is not able to fully achieve its plan, the Company may need to raise additional funds through equity or debt financing. If the Company is unsuccessful in raising additional financing, it will need to reduce costs and operations in the future.

 

Cash Flows

 

   For the nine months ended 
   September 30, 
   2016   2015 
         
Net Cash (Used in) Operating Activities  $(1,711,819)  $(4,804,778)
Net Cash (Used in) Investing Activities   (42,007)   (88,156)
Net Cash Provided by Financing Activities   1,561,082    3,271,943 
Decrease in Cash  $(192,744)  $(1,620,991)

 

We had cash in the amount of $1,494,513 and $1,687,257 as of September 30, 2016 and December 31, 2015, respectively.

 

23 

 

 

On April 18, 2016 (the “Initial Closing Date”), the Company entered into a Common Stock and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors for the issuance and sale of 11,714,285 shares of common stock of the Company and warrants to purchase up to an aggregate of 1,312,000 shares of Common Stock, representing up to $1,640,000 of proceeds, in one or more closings within 30 days of the Initial Closing Date (the “Transaction”). The warrants are exercisable at $0.25 per share for five years from the date of issuance and subject to anti-dilution protection as defined. As of July 23, 2016, the Company had received proceeds, net of costs, of $1,579,082.

 

Critical Accounting Policies

 

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with the accounting principles generally accepted in the United States. Preparing financial statements requires our management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by our management’s application of accounting policies. We believe that understanding the basis and nature of the estimates and assumptions involved with the following aspects of our financial statements is critical to an understanding of our financial statements.

 

Our critical accounting policies, as described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, relate to capitalized legal patent costs, income taxes, goodwill, intangible assets, share-based payments, revenue recognition, and research and other accounting descriptions. There have been no material changes to our critical accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow for timely decisions regarding required disclosure.  Our management carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures.  Based on that evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2016 in accordance with generally accepted accounting principles. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2014 as filed with the SEC on July 10, 2015 for a complete discussion relating to the foregoing evaluation of our controls and procedures.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

24 

 

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

In April 2015, two shareholder class action lawsuits were filed against the Company and former officers Nathaniel Bradley and Edward O’Donnell in the U.S. District Court for the District of Arizona. The plaintiffs allege various causes of action against the defendants arising from our announcement that our previously issued financial results for the first three quarters of 2014 and the guidance for the fourth quarter of 2014 and the full year of 2014 could no longer be relied upon.  The complaints sought among other relief, compensatory damages and plaintiff’s counsel’s fees and experts’ fees. The Court appointed a lead plaintiff and lead counsel, and consolidated the actions. A consolidated amended complaint was filed under the caption In re AudioEye, Inc. Sec. Litigation. The Company and individual defendants filed a motion to dismiss. 

 

On July 25, 2016, in connection with a voluntary mediation, the parties reached an agreement in principle to settle the consolidated actions. The settlement agreement is subject to definitive documentation, shareholder notice, and court approval. The terms of the agreement include a settlement payment to the class of $1,525,000 from the Company’s insurer, with no admission of liability by any party. In 2015, the Company paid a deductible under its D&O insurance policy in the amount of $100,000 regarding this matter.

 

On May 16, 2016, a shareholder derivative complaint entitled LiPoChing, Derivatively and on Behalf of AudioEye, Inc., v. Bradley, et al., was filed in the United States District Court for the District of Arizona. As a derivative complaint, the plaintiff-shareholder purports to act on behalf of the Company against certain of the Company's current and former officers and directors (the “Named Individuals”). The Company is named as a nominal defendant. The complaint asserts causes of action including breach of fiduciary duty and others, arising from the Company’s restatement of its financial results for the first three quarters of 2014. The complaint seeks, among other relief, compensatory damages, restitution and attorneys’ fees. No discovery has occurred. In October 2016, the Company and Named Defendants filed a motion to dismiss, which remains pending. While the Company believes that its legal defense costs may be reimbursed by the Company’s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement.

 

 On July 26, 2016, a shareholder derivative complaint entitled Denese M. Hebert, derivatively on Behalf of Nominal Defendant AudioEye, Inc., v. Bradley, et al., was filed in the State of Arizona Superior Court for Pima County. The complaint generally asserts causes of action related to the Company’s restatement of its financial statements for the first three fiscal quarters of 2014.  As a derivative complaint, the plaintiff-shareholder purports to act on behalf of the Company against certain of the Company's current and former officers and directors (the “Named Individuals”). The Company is named as a nominal defendant. The Company understands that the Named Individuals intend to vigorously defend the lawsuit. While the Company believes that its legal defense costs may be reimbursed by the Company’s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement.

 

We may become involved in various other routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.

 

25 

 

 

Item 1A. Risk Factors

 

There have been no material changes from the risk factors disclosed in Item 1.A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2015.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

Exhibit
No.
  Description
31.1*   Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1*   Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS*   XBRL Instance Document
     
101.SCH*   XBRL Taxonomy Extension Schema Document
     
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document

 

*Filed herewith.

 

26 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 14 day of November 2016.

 

 

  AUDIOEYE, INC.
     
  By:   /s/ Dr. Carr Bettis
    Dr. Carr Bettis
    Principal Executive Officer
     
  By: /s/ Todd Bankofier
    Todd Bankofier
    Chief Executive Officer

 

27 

EX-31.1 2 v451978_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Carr Bettis, Principal Executive Officer of AudioEye, Inc. (the “Registrant”), certify that:

 

1.       I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2016 of AudioEye, Inc. (the “Quarterly Report”);

 

2.       Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Quarterly Report;

 

4.       The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

(a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

 

(b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)       Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Annual Report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Quarterly Report based on such evaluation; and

 

(d)       Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5.       The Registrant’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

(a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

(b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

 

Date: November 14, 2016 By: /s/ Carr Bettis
    Name: Carr Bettis
    Title: Principal Executive Officer and Principal Financial Officer

 

 

 

EX-32.1 3 v451978_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

 

CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the filing by AudioEye, Inc. (the “Registrant”) of its Quarterly Report on Form 10-Q for the period ended September 30, 2016 (the “Quarterly Report”) with the Securities and Exchange Commission, I, Carr Bettis, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(i)       The Quarterly Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(ii)       The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

A signed original of this written statement required by Section 906 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.

 

Date: November 14, 2016 By: /s/ Carr Bettis
    Name: Carr Bettis
    Title: Principal Executive Officer and Principal Financial Officer

  

 

EX-101.INS 4 aeye-20160930.xml XBRL INSTANCE DOCUMENT 0001362190 2015-01-01 2015-09-30 0001362190 2015-01-01 2015-12-31 0001362190 2016-01-01 2016-01-15 0001362190 2016-01-01 2016-09-30 0001362190 2016-04-01 2016-04-30 0001362190 2016-04-01 2016-05-31 0001362190 2016-04-30 0001362190 2016-05-01 2016-05-31 0001362190 2016-05-31 0001362190 2015-07-01 2015-09-30 0001362190 2016-07-01 2016-07-25 0001362190 2016-07-01 2016-07-31 0001362190 2016-07-01 2016-09-30 0001362190 2016-08-01 2016-08-31 0001362190 2016-09-01 2016-09-30 0001362190 2016-09-30 0001362190 2015-10-01 2015-10-15 0001362190 2015-10-01 2015-11-30 0001362190 2015-10-03 2015-10-09 0001362190 2015-10-09 0001362190 2015-11-08 0001362190 2016-11-14 0001362190 2015-11-30 0001362190 2015-12-31 0001362190 2014-12-31 0001362190 2015-09-30 0001362190 us-gaap:CommonStockMember 2015-12-31 0001362190 us-gaap:PreferredStockMember 2015-12-31 0001362190 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001362190 us-gaap:NoncontrollingInterestMember 2015-12-31 0001362190 us-gaap:RetainedEarningsMember 2015-12-31 0001362190 us-gaap:CommonStockMember 2016-01-01 2016-09-30 0001362190 us-gaap:PreferredStockMember 2016-01-01 2016-09-30 0001362190 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-09-30 0001362190 us-gaap:NoncontrollingInterestMember 2016-01-01 2016-09-30 0001362190 us-gaap:RetainedEarningsMember 2016-01-01 2016-09-30 0001362190 us-gaap:CommonStockMember 2016-09-30 0001362190 us-gaap:PreferredStockMember 2016-09-30 0001362190 us-gaap:AdditionalPaidInCapitalMember 2016-09-30 0001362190 us-gaap:NoncontrollingInterestMember 2016-09-30 0001362190 us-gaap:RetainedEarningsMember 2016-09-30 0001362190 us-gaap:WarrantMember 2015-10-03 2015-10-09 0001362190 us-gaap:MinimumMember 2016-05-31 0001362190 us-gaap:MaximumMember 2016-05-31 0001362190 us-gaap:MinimumMember 2016-04-01 2016-05-31 0001362190 us-gaap:MaximumMember 2016-04-01 2016-05-31 0001362190 us-gaap:MinimumMember 2016-01-01 2016-09-30 0001362190 us-gaap:MaximumMember 2016-01-01 2016-09-30 0001362190 us-gaap:FairValueInputsLevel1Member 2015-12-31 0001362190 us-gaap:FairValueInputsLevel1Member 2016-09-30 0001362190 us-gaap:FairValueInputsLevel3Member 2015-12-31 0001362190 us-gaap:FairValueInputsLevel3Member 2016-09-30 0001362190 us-gaap:ExecutiveOfficerMember 2016-09-30 0001362190 us-gaap:ExecutiveOfficerMember 2016-01-01 2016-09-30 0001362190 us-gaap:VicePresidentMember 2016-09-30 0001362190 us-gaap:VicePresidentMember 2015-12-31 0001362190 us-gaap:ExecutiveOfficerMember 2015-12-31 0001362190 aeye:DavidMoradiMember 2015-12-31 0001362190 us-gaap:PatentsMember 2016-01-01 2016-09-30 0001362190 us-gaap:PatentsMember 2015-01-01 2015-09-30 0001362190 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2016-09-30 0001362190 us-gaap:PatentsMember 2016-09-30 0001362190 us-gaap:PatentsMember 2015-12-31 0001362190 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2015-12-31 0001362190 us-gaap:ConstructionInProgressMember 2016-01-01 2016-09-30 0001362190 us-gaap:PatentsMember 2016-07-01 2016-09-30 0001362190 us-gaap:ConstructionInProgressMember 2016-07-01 2016-09-30 0001362190 us-gaap:PatentsMember 2015-07-01 2015-09-30 0001362190 us-gaap:ConstructionInProgressMember 2015-07-01 2015-09-30 0001362190 us-gaap:ConstructionInProgressMember 2015-01-01 2015-09-30 0001362190 us-gaap:NotesPayableOtherPayablesMember 2016-09-30 0001362190 us-gaap:NotesPayableOtherPayablesMember 2015-12-31 0001362190 us-gaap:NotesPayableOtherPayablesMember 2011-10-24 0001362190 us-gaap:LoansPayableMember 2012-12-31 0001362190 us-gaap:NotesPayableOtherPayablesMember 2011-10-01 2011-10-24 0001362190 us-gaap:NotesPayableOtherPayablesMember 2016-01-01 2016-09-30 0001362190 aeye:NotesPayableMember 2015-10-09 0001362190 aeye:NoteAndWarrantPurchaseAgreementMember 2015-10-09 0001362190 aeye:NotesPayableMember 2015-11-09 0001362190 aeye:NotesPayableMember 2015-10-03 2015-10-09 0001362190 aeye:NoteAndWarrantPurchaseAgreementMember 2015-10-03 2015-10-09 0001362190 aeye:NotesPayableMember us-gaap:MaximumMember 2015-10-03 2015-10-09 0001362190 aeye:NotesPayableMember us-gaap:MinimumMember 2015-10-03 2015-10-09 0001362190 aeye:AmendmentsToExistingAgreementsMember 2016-04-01 2016-04-18 0001362190 aeye:AmendmentsToExistingAgreementsMember 2016-04-18 0001362190 us-gaap:ConvertibleNotesPayableMember 2016-01-01 2016-09-30 0001362190 aeye:BlackscholesOptionPricingModelMember 2016-09-30 0001362190 aeye:BlackscholesOptionPricingModelMember 2016-01-01 2016-09-30 0001362190 us-gaap:ConvertibleNotesPayableMember 2016-09-30 0001362190 us-gaap:SeriesAPreferredStockMember 2016-01-01 2016-09-30 0001362190 us-gaap:SeriesAPreferredStockMember 2016-09-30 0001362190 us-gaap:SeriesAPreferredStockMember 2015-12-31 0001362190 us-gaap:SeriesAPreferredStockMember 2016-05-01 2016-05-31 0001362190 us-gaap:EmployeeStockOptionMember 2016-09-30 0001362190 us-gaap:EmployeeStockOptionMember 2015-12-31 0001362190 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-09-30 0001362190 aeye:PerformanceOptionsMember 2016-01-01 2016-01-15 0001362190 aeye:NonPerformanceOptionsMember us-gaap:MinimumMember 2016-01-01 2016-09-30 0001362190 aeye:NonPerformanceOptionsMember us-gaap:MaximumMember 2016-01-01 2016-09-30 0001362190 aeye:NonPerformanceOptionsMember 2016-01-01 2016-09-30 0001362190 aeye:OptionsGrantedOnMay2016OneMember 2016-05-01 2016-05-12 0001362190 aeye:OptionsGrantedOnMay2016OneMember 2016-05-12 0001362190 aeye:OptionsGrantedOnMay2016OneMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2016-05-01 2016-05-12 0001362190 aeye:OptionsGrantedOnMay2016OneMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2016-05-01 2016-05-12 0001362190 aeye:OptionsGrantedOnApril2016Member 2016-04-01 2016-04-15 0001362190 aeye:OptionsGrantedOnApril2016Member 2016-04-15 0001362190 aeye:OptionsGrantedOnMay2016TwoMember 2016-05-01 2016-05-12 0001362190 aeye:OptionsGrantedOnMay2016TwoMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2016-05-01 2016-05-12 0001362190 aeye:OptionsGrantedOnMay2016TwoMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2016-05-01 2016-05-12 0001362190 aeye:OptionsGrantedOnMay2016TwoMember 2016-05-12 0001362190 aeye:PerformanceOptionsMember aeye:PerformanceAndMarketConditionsMember 2016-01-01 2016-01-15 0001362190 us-gaap:EmployeeStockOptionMember 2016-07-01 2016-09-30 0001362190 us-gaap:EmployeeStockOptionMember 2015-07-01 2015-09-30 0001362190 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-09-30 0001362190 us-gaap:WarrantMember us-gaap:MinimumMember 2016-01-01 2016-09-30 0001362190 us-gaap:WarrantMember us-gaap:MaximumMember 2016-01-01 2016-09-30 0001362190 us-gaap:WarrantMember 2016-01-01 2016-09-30 0001362190 us-gaap:WarrantMember 2016-09-30 0001362190 us-gaap:WarrantMember 2016-07-01 2016-09-30 0001362190 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001362190 us-gaap:MinimumMember 2016-09-30 0001362190 us-gaap:MaximumMember 2016-09-30 0001362190 us-gaap:ConvertibleNotesPayableMember 2016-04-01 2016-04-30 0001362190 us-gaap:WarrantMember 2015-07-01 2015-09-30 0001362190 aeye:SeanBradleyMember 2016-10-10 2016-10-15 0001362190 us-gaap:StockCompensationPlanMember 2016-10-10 2016-10-15 0001362190 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2016-07-01 2016-09-30 0001362190 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-09-30 0001362190 aeye:CustomerOneMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-09-30 0001362190 aeye:CustomerTwoMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-09-30 0001362190 aeye:CustomerThreeMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-09-30 0001362190 aeye:CustomerFourMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-09-30 0001362190 aeye:CustomerOneMember us-gaap:AccountsReceivableMember 2016-01-01 2016-09-30 0001362190 aeye:CustomerTwoMember us-gaap:AccountsReceivableMember 2016-01-01 2016-09-30 0001362190 aeye:CustomerThreeMember us-gaap:AccountsReceivableMember 2016-01-01 2016-09-30 0001362190 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-12-31 0001362190 aeye:OptionsGrantedOnJuly2016Member 2016-07-01 2016-07-15 0001362190 aeye:OptionsGrantedOnJuly2016Member 2016-07-15 0001362190 us-gaap:MinimumMember aeye:BlackscholesOptionPricingModelMember 2015-11-30 0001362190 us-gaap:MaximumMember aeye:BlackscholesOptionPricingModelMember 2015-11-30 0001362190 aeye:BlackscholesOptionPricingModelMember 2015-10-01 2015-11-30 0001362190 us-gaap:MinimumMember aeye:BlackscholesOptionPricingModelMember 2015-10-01 2015-11-30 0001362190 us-gaap:MaximumMember aeye:BlackscholesOptionPricingModelMember 2015-10-01 2015-11-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 57828 41388 1626440 1804986 2454162 2840856 700528 700528 4781130 5346370 267377 213620 24000 24000 14744 153474 4368446 891245 5800 1923499 4374246 2814744 2 2 1074 817 623000 623000 33997819 27393238 -32969011 -24239431 406884 2531626 4781130 5346370 1494513 1687257 20499 22741 3600 3600 50000 50000 414082 60790 3648243 439361 904091 1178388 -309854 -864242 510448 747990 255805 293877 1894964 4161269 428701 396269 3089918 5599405 -3399772 -6463647 594237 314146 -2990096 0 -676181 3345 -5329808 3345 -8729580 -6460302 -0.09 -0.09 95840596 80007507 60000 594641 -8789580 -7054943 311519 321755 -28843 -213070 192881 171594 85192 92857 602041 -27278 150328 128381 1030442 365554 -1059285 -578624 282676 108685 351055 0 266 81 352221 81 -707064 -578543 -0.01 -0.01 107382344 81800488 20000 0 -727064 -578543 900 0 0 0 0 0 -1664281 0 0 0 750 0 817 2 27393238 -623000 -24239431 81717154 175000 47458 3 0 47455 0 0 291666 0 1078123 128 0 1077995 0 0 12834800 0 1579082 117 0 1578965 0 0 11714285 0 900525 -15000 0 9 0 -9 0 0 3205959 0 0 3205959 0 0 -218786 0 0 -218786 0 0 913002 0 0 913002 0 0 0 0 0 0 -8729580 1074 2 33997819 -623000 -32969011 107458430 160000 428701 396269 913002 1200459 679972 600301 0 -2242 -212662 173558 -517743 -1711819 -4804778 -42007 -88156 1579082 325000 0 -1175000 1561082 3271943 -192744 -1620991 1687257 1672901 1494513 51910 0 43943 -11650 16440 42007 88156 0 307 0 0 -18000 -22000 -138730 -226483 353292 0 47458 0 -57012 1078123 3205959 0 1750000 0 0 0 218786 0 594641 P5Y 25000000 2500000 0.10 2990096 0.0025 0.169 0.195 1.69 0.0122 0.0135 0.10 0.10 1.78 0.25 0.25 0.149 0.0114 3648243 P4Y7D P4Y6M22D 1.7052 218786 3600 3600 439361 3648243 2742006 906237 1579082 5992 500 8752 6250 1500 72944 70000 4280 4500 42007 88156 1864481 1435780 2840856 2454162 621567 3697076 3655069 621567 281064 147637 94209 56119 428701 395617 87395 268940 40427 126677 24000 24000 5800 23800 0 1899699 149800 0.25 74900 29800 47800 2000 74900 18000 3750000 37500000 2500000 1000000 0.6 0.1 0.10 2500000 627293 0 2000000 1000000 12834800 18353310 2500000 119801 0.001 1025000 18353310 0.175 0.0124 P5Y 3205959 1541678 1664281 1.78 0.84 107458430 81717154 0.05 160000 175000 10 0.1754 83336 14292 12834800 1025000 11714285 1312000 1579082 900525 15000 25005504 14759914 510500 0.08 0.78 10756090 13177211 0 0 0.30 0.20 8374294 417857 0 0.038 P5Y 1.62 0.0146 0 1.0200 0.0173 0 100000 2021-05-12 16694 0.5 0.0417 0.177 49715 0.179 2019-04-15 6250 3400000 0.5 0.5 0.177 2021-05-12 559603 6500000 5500000 P1Y6M P3Y6M 166111 706230 -119224 709311 21961513 0 0.02 P4Y7M28D 0 42526609 64095041 0.22 0.15 P4Y1M24D P3Y8M23D 41297920 63907541 393081 0.42 1167 4059950 P1Y6M P2Y6M 1.6674 1.7898 0.0071 0.0108 0 150500 1575954 18353311 P5Y 58599 20962 491148 0.038 0.179 18353310 1541678 0.001 206772 10-Q false 2016-09-30 2016 Q3 AUDIOEYE INC 0001362190 --12-31 Smaller Reporting Company AEYE 107500096 0.00001 0.00001 10000000 10000000 160000 175000 160000 175000 0.00001 0.00001 250000000 250000000 107458430 41666 4292 61599 0.125 81717154 P3Y 0 44250 0.55 0.43 0.21 0.16 0.15 0.11 0.24 0.17 0.15 P4Y10M10D P3Y7M10D P3Y6M7D 56375 0.156 2019-07-15 6250 1.7499 0.0087 In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the &#8220;Purchase Agreement Amendment&#8221;) and an Omnibus Amendment to Secured Promissory Notes (the &#8220;Note Amendment&#8221;), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the &#8220;Original Agreement&#8221;) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, &#8220;Anthion&#8221;) to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of &#8220;qualified financing&#8221; under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing &#8220;blocker&#8221; provisions (&#8220;Special Warrants&#8221;) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar &#8220;blocker&#8221; provisions. Vesting shall only occur if the closing share price of the Companys common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition) 124998 20666 41666 6208 41666 6292 P5Y 60918 1312000 0.031 0.058 1.02 0.0114 0.0175 P5Y P5Y P5Y <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>NOTE 10: SUBSEQUENT EVENTS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Employee options/warrants</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On October 15, 2016, the Company granted 61,599 options to Sean Bradley as compensation for services rendered. The options are exercisable at $0.125 for three years, vesting immediately. The exercise price was determined using the 10-day average closing price beginning with the closing price on October 1, 2016.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Common stock</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In October 2015, the Company issued 41,666 shares of its common stock for consulting services rendered valued at $4,292.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>NOTE 5: NOTES PAYABLE</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 30, 2016 and December 31, 2015, the Company has short term and long term notes payable of $24,000 and $5,800, and $24,000 and $1,923,499, respectively as shown in the table below.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>Notes and loans payable</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-SIZE: 10pt; FONT-WEIGHT: bold" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-SIZE: 10pt; FONT-WEIGHT: bold" colspan="2"> <div>December 31,<br/> 2015</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt; TEXT-DECORATION: underline"> <div>Short Term</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; WIDTH: 68%; FONT-SIZE: 10pt"> <div>Maryland TEDCO</div> </td> <td style="PADDING-BOTTOM: 1pt; WIDTH: 2%; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; WIDTH: 12%; FONT-SIZE: 10pt"> <div>24,000</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; WIDTH: 1%; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 1pt; WIDTH: 2%; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; WIDTH: 12%; FONT-SIZE: 10pt"> <div>24,000</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; WIDTH: 1%; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>Total</div> </td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>24,000</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>24,000</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt; TEXT-DECORATION: underline"> <div>Long Term</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>Convertible Secured Note (net of unamortized discounts of $600,301 in 2015)</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>1,899,699</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>Maryland TEDCO</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>5,800</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>23,800</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>Total</div> </td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>5,800</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>1,923,499</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of December&#160;31, 2012, the Company had an outstanding loan to a third party in the amount of $74,900, which was originally issued during 2006 as part of an Investment Agreement.&#160;The loan was unsecured and bore interest at 25% per year for four years. The Company had accrued interest of $74,900, which was included in accounts payable and accrued expenses on the consolidated balance sheets.&#160; The note was in default until October&#160;24, 2011, at which time the Company entered into a Termination and Release Agreement (&#8220;Release&#8221;) with the third party.&#160; The terms of the Release, among other things, terminated the Investment Agreement between the parties, and required the Company to issue a Promissory Note to the third-party in the combined amount of principal and accrued interest to date, for a total principal amount of $149,800.&#160; The note is interest free, and is payable in monthly installments of $2,000 beginning November&#160;1, 2011.&#160; As of September 30, 2016 and December&#160;31,&#160;2015, the principal amount owing was $29,800 and $47,800, respectively, of which $24,000 and $24,000, respectively, has been recorded as the current portion of the note, and $5,800 and $23,800, respectively, as the long-term portion of the note. The Company has paid $18,000 for the nine months ended September 30, 2016.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On October 9, 2015 (the &#8220;Initial Closing Date&#8221;), AudioEye, Inc. (the &#8220;Company&#8221;) entered into a Note and Warrant Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain investors (the &#8220;Investors&#8221;) for the issuance and sale of convertible promissory notes in an aggregate principal amount of up to $3,750,000 (the &#8220;Notes&#8221;) and warrants (the &#8220;Warrants&#8221;) to purchase up to an aggregate of 37,500,000 shares of common stock of the Company (the &#8220;Common Stock&#8221;) (the &#8220;Transaction&#8221;). Notes representing up to $2,500,000 in aggregate principal, and Warrants exercisable for up to 25,000,000 shares of Common Stock in the aggregate, may be issued and sold at one or more closings during the 30-day period immediately following the Initial Closing Date. The maximum of $2,500,000 in aggregate principal was sold as of November 8, 2015. In addition, upon the election of any Investor within the three-year period immediately following the Initial Closing Date, any Investor may purchase an additional Note in the principal amount equal to 50% of the principal amount of the Notes purchased by such Investor at previous closings (the &#8220;Option Principal Amount&#8221;) and an additional Warrant with an aggregate exercise price equal to such Investor&#8217;s Option Principal Amount.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Notes mature three years from the date of issuance (the &#8220;Maturity Date&#8221;) and, until the Notes are repaid or converted into shares of the Company&#8217;s equity securities (&#8220;Equity Securities&#8221;), accrue payable-in-kind interest at the rate of 10% per annum. As described in the Purchase Agreement, as amended (see below), if the Company sold Equity Securities in a single transaction or series of related transactions for cash of at least $1,000,000 (excluding the conversion of the Notes and excluding the shares of Common Stock to be issued upon exercise of the Warrants) on or before the Maturity Date (the &#8220;Equity Financing&#8221;), all of the unpaid principal on the Notes plus accrued interest shall be automatically converted at the closing of the Equity Financing into a number of shares of the same class or series of Equity Securities as are issued and sold by the Company in such Equity Financing (or a class or series of Equity Securities identical in all respects to and ranking pari passu with the class or series of Equity Securities issued and sold in such Equity Financing) as is determined by dividing (i) the principal and accrued and unpaid interest amount of the Notes by (ii) 60% of the price per share at which such Equity Securities are issued and sold in such Equity Financing. The Notes, if not converted, shall be due and payable in full on the Maturity Date.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Notes contained customary events of default provisions. In connection with the issuance of the Notes, on October 9, 2015, the Company entered into a Security Agreement with the Investors (the &#8220;Security Agreement&#8221;) pursuant to which the Company granted a security interest in all of its assets to the Investors as collateral for the Company&#8217;s obligations under the Notes. As noted below, on April 18, 2016, the parties agreed to remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Warrants are exercisable at $0.10 per share and expire 60 months following the date of issuance. The Warrants are subject to anti-dilution protection, subject to certain customary exceptions.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> During 2015, the Company issued notes under this offering totaling $2,500,000. The fair value of the warrants issued in connection with the notes was determined to be $627,293 and was recognized as a discount to the debt being amortized to interest expense over the life of the loans. During three and nine months ended September 30, 2016, aggregate amortization (and write-off) of $-0- and $600,301 was recognized against the discount.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the &#8220;Purchase Agreement Amendment&#8221;) and an Omnibus Amendment to Secured Promissory Notes (the &#8220;Note Amendment&#8221;), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the &#8220;Original Agreement&#8221;) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, &#8220;Anthion&#8221;) to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of &#8220;qualified financing&#8221; under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing &#8220;blocker&#8221; provisions (&#8220;Special Warrants&#8221;) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar &#8220;blocker&#8221; provisions.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On April 18, 2016, the Company issued an aggregate of 12,834,800 shares of its common stock to the Note holders other than Anthion, and 18,353,310 warrants to acquire its common stock to Anthion in lieu of common stock. Collectively the common stock and warrants issued were in full settlement of $2,500,000 convertible notes and accrued interest of $119,801. The warrants issued to Anthion are exercisable at $0.001 per share for five years from the date of issuance.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> At the date of conversion, the Company determined that the conversion price of $0.84 per share did not exceed the fair value of Common Stock at note inception, therefore there was no beneficial conversion feature upon conversion of $1,025,000 of convertible notes and accrued interest. However, the Company determined that the estimated fair value of the 18,353,310 warrants of $3,205,959 exceeded the settlement of $1,541,678 of convertible notes and accrued interest and accordingly recorded a loss of settlement of debt of $1,664,281 for the nine months ended September 30, 2016. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the warrants at the date of conversion using the following assumptions: the price of the Company stock of $0.175, volatility was estimated to be 178%, the risk free rate of 1.24% and the remaining term was 5 years.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 2500000 25000000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 30, 2016 and December 31, 2015, the Company has short term and long term notes payable of $24,000 and $5,800, and $24,000 and $1,923,499, respectively as shown in the table below.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>Notes and loans payable</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-SIZE: 10pt; FONT-WEIGHT: bold" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-SIZE: 10pt; FONT-WEIGHT: bold" colspan="2"> <div>December 31,<br/> 2015</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt; TEXT-DECORATION: underline"> <div>Short Term</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; WIDTH: 68%; FONT-SIZE: 10pt"> <div>Maryland TEDCO</div> </td> <td style="PADDING-BOTTOM: 1pt; WIDTH: 2%; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; WIDTH: 12%; FONT-SIZE: 10pt"> <div>24,000</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; WIDTH: 1%; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 1pt; WIDTH: 2%; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; WIDTH: 12%; FONT-SIZE: 10pt"> <div>24,000</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; WIDTH: 1%; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>Total</div> </td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>24,000</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>24,000</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt; TEXT-DECORATION: underline"> <div>Long Term</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>Convertible Secured Note (net of unamortized discounts of $600,301 in 2015)</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>1,899,699</div> </td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>Maryland TEDCO</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>5,800</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>23,800</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>Total</div> </td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>5,800</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT-SIZE: 10pt"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT-SIZE: 10pt"> <div>1,923,499</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> <div>&#160;</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The following are the Company&#8217;s assets and liabilities, measured at fair value on a recurring basis, as of September 30, 2016 and December&#160;31, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair Value</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair Value</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Hierarchy</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Assets</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="68%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Marketable securities, September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="12%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,600</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="14%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 1</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Marketable securities, December 31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,600</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 1</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Liabilities</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Derivative Liability , September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,648,243</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 3</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Derivative Liability , December 31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 439,361</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 3</font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Corporate Information and Background</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> AudioEye,&#160;Inc. was formed as a Delaware corporation on May&#160;20, 2005. The Company focuses on providing its customers with the most complete and inclusive web accessibility solution available. The Company&#8217;s suite of technologies allows its customers to provide their site visitors with an enhanced web experience. When implemented, the Company believes its solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty. In addition, the Company&#8217;s solutions provide organizations with the ability to comply with internationally accepted web content accessibility guidelines (WCAG) as well as United States, Canadian and United Kingdom accessibility laws.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Reclassification</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Revenue Recognition</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Revenue is recognized when all applicable recognition criteria have been met, which generally include (a)&#160;persuasive evidence of an existing arrangement; (b)&#160;fixed or determinable price; (c)&#160;delivery has occurred or service has been rendered; and (d)&#160;collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a)&#160;estimate of total hours and milestones to complete; (b)&#160;total hours completed; (c)&#160;delivery of services rendered; (d)&#160;change in estimates; and (e)&#160;collectability of the contract.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company had one major customer including their affiliates which generated approximately 55% of its revenue in the three months ended September 30, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company had four major customers including their affiliates which generated approximately 43% (21%, 16%, 15% and 11%) of its revenue in the nine months ended September 30, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">At September 30, 2016, the Company had three customers representing 24%, 17% and 15% of the outstanding accounts receivable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Certain Software as a Service (SaaS) and website hosting contracts are prepared and invoiced on an annual basis. Any funds received for hosting services not provided yet are held in deferred revenue, and are recorded as revenue when earned.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman', 'serif'; BACKGROUND: transparent; FONT-SIZE: 10pt"> Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company&#8217;s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Stock based compensation</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Derivative Instrument Liability</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At September 30, 2016 and December 31, 2015, the Company did not have any derivative instruments that were designated as hedges.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On October 9, 2015, the Company issued convertible promissory notes representing $2,500,000 in aggregate principal together with warrants exercisable for up to 25,000,000 shares of Common Stock. The warrants have a strike price of $0.10 and term of 5 years. In addition on May 9, 2016, in connection with the sale of the Company&#8217;s common stock, the Company issued warrants exercisable for up to 1,312,000 shares of Common Stock. The warrants have a strike price of $0.25 and a term of 5 years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In accordance with ASC 815, these outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company&#8217;s common stock and is recorded as a current liability on the Company&#8217;s Consolidated Balance Sheets. The change in the value of the liability is recorded as &#8220;unrealized gain (loss) on derivative liability&#8221; on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the &#8220;operating activities&#8221; of the Consolidated Statements of Cash Flow. At September 30, 2016 and December 31, 2015, the derivative liability was stated at $3,648,243 and $439,361, respectively. The change in fair value of $2,990,096 was driven by the increased value of the Company&#8217;s common stock in the period and recorded as the &#8220;Loss on change in derivative liability&#8221; in the Consolidated Statements of Operations for the nine months ended September 30, 2016. As the warrants are exercised or expire, the derivative liability will be adjusted on the balance sheet and an adjustment will be reflected in stockholders equity under additional paid-in capital.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair Value Measurements</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels:&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">An asset or liability&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In October and November 2015, the Company issued warrants with an exercise price of $0.10 in connection with a convertible debt instruments. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.10 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company&#8217;s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption &#8220;unrealized gain/(loss) &#150; derivative liability&#8221; until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.031 to $0.058, volatility was estimated to be 102%, the risk free rate ranged 1.14% to 1.75% and the remaining term was 5 years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In April and May 2016, the Company issued warrants with an exercise price of $0.25 in connection with the sale of Common Stock. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.25 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company&#8217;s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption &#8220;unrealized gain/(loss) &#150; derivative liability&#8221; until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.169 to $0.195, volatility was estimated to be from 169% to 178%, the risk free rate ranged 1.22% to 1.35% and the remaining term was 5 years. The estimated initial fair value of these warrants of $218,786 was reclassified from equity to liability at the date of issuance.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">At September 30, 2016, the price of the Company stock was 0.149, volatility was estimated to be 170.52%, the risk free rate of 1.14% and the remaining term ranged from 4.02 to 4.56 years. As of September 30, 2016, the fair value of the warrants was determined to be $3,648,243, resulting in an unrealized gain (loss) on the change in the fair value of this derivative liability of $351,055 and $(2,990,096) for the three and nine months ended September 30, 2016, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The following are the Company&#8217;s assets and liabilities, measured at fair value on a recurring basis, as of September 30, 2016 and December&#160;31, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair Value</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair Value</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Hierarchy</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Assets</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="68%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Marketable securities, September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="12%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,600</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="14%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 1</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Marketable securities, December 31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,600</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 1</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Liabilities</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Derivative Liability , September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,648,243</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 3</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Derivative Liability , December 31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 439,361</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 3</font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Recent Accounting Pronouncements</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The accompanying unaudited interim financial statements of AudioEye,&#160;Inc. and its wholly-owned subsidiary (collectively, the &#8220;Company&#8221;) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules&#160;of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company&#8217;s Annual Report on Form&#160;10-K filed with the Securities and Exchange Commission on March 30, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein.&#160;The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended December&#160;31, 2015 as reported in the Company&#8217;s Annual Report on Form&#160;10-K have been omitted.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Corporate Information and Background</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> AudioEye,&#160;Inc. was formed as a Delaware corporation on May&#160;20, 2005. The Company focuses on providing its customers with the most complete and inclusive web accessibility solution available. The Company&#8217;s suite of technologies allows its customers to provide their site visitors with an enhanced web experience. When implemented, the Company believes its solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty. In addition, the Company&#8217;s solutions provide organizations with the ability to comply with internationally accepted web content accessibility guidelines (WCAG) as well as United States, Canadian and United Kingdom accessibility laws.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Reclassification</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Revenue Recognition</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Revenue is recognized when all applicable recognition criteria have been met, which generally include (a)&#160;persuasive evidence of an existing arrangement; (b)&#160;fixed or determinable price; (c)&#160;delivery has occurred or service has been rendered; and (d)&#160;collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a)&#160;estimate of total hours and milestones to complete; (b)&#160;total hours completed; (c)&#160;delivery of services rendered; (d)&#160;change in estimates; and (e)&#160;collectability of the contract.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company had one major customer including their affiliates which generated approximately 55% of its revenue in the three months ended September 30, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company had four major customers including their affiliates which generated approximately 43% (21%, 16%, 15% and 11%) of its revenue in the nine months ended September 30, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">At September 30, 2016, the Company had three customers representing 24%, 17% and 15% of the outstanding accounts receivable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Certain Software as a Service (SaaS) and website hosting contracts are prepared and invoiced on an annual basis. Any funds received for hosting services not provided yet are held in deferred revenue, and are recorded as revenue when earned.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman', 'serif'; BACKGROUND: transparent; FONT-SIZE: 10pt"> Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company&#8217;s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Stock based compensation</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Derivative Instrument Liability</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At September 30, 2016 and December 31, 2015, the Company did not have any derivative instruments that were designated as hedges.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On October 9, 2015, the Company issued convertible promissory notes representing $2,500,000 in aggregate principal together with warrants exercisable for up to 25,000,000 shares of Common Stock. The warrants have a strike price of $0.10 and term of 5 years. In addition on May 9, 2016, in connection with the sale of the Company&#8217;s common stock, the Company issued warrants exercisable for up to 1,312,000 shares of Common Stock. The warrants have a strike price of $0.25 and a term of 5 years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In accordance with ASC 815, these outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company&#8217;s common stock and is recorded as a current liability on the Company&#8217;s Consolidated Balance Sheets. The change in the value of the liability is recorded as &#8220;unrealized gain (loss) on derivative liability&#8221; on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the &#8220;operating activities&#8221; of the Consolidated Statements of Cash Flow. At September 30, 2016 and December 31, 2015, the derivative liability was stated at $3,648,243 and $439,361, respectively. The change in fair value of $2,990,096 was driven by the increased value of the Company&#8217;s common stock in the period and recorded as the &#8220;Loss on change in derivative liability&#8221; in the Consolidated Statements of Operations for the nine months ended September 30, 2016. As the warrants are exercised or expire, the derivative liability will be adjusted on the balance sheet and an adjustment will be reflected in stockholders equity under additional paid-in capital.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair Value Measurements</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels:&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">An asset or liability&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In October and November 2015, the Company issued warrants with an exercise price of $0.10 in connection with a convertible debt instruments. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.10 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company&#8217;s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption &#8220;unrealized gain/(loss) &#150; derivative liability&#8221; until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.031 to $0.058, volatility was estimated to be 102%, the risk free rate ranged 1.14% to 1.75% and the remaining term was 5 years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In April and May 2016, the Company issued warrants with an exercise price of $0.25 in connection with the sale of Common Stock. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.25 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company&#8217;s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption &#8220;unrealized gain/(loss) &#150; derivative liability&#8221; until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.169 to $0.195, volatility was estimated to be from 169% to 178%, the risk free rate ranged 1.22% to 1.35% and the remaining term was 5 years. The estimated initial fair value of these warrants of $218,786 was reclassified from equity to liability at the date of issuance.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">At September 30, 2016, the price of the Company stock was 0.149, volatility was estimated to be 170.52%, the risk free rate of 1.14% and the remaining term ranged from 4.02 to 4.56 years. As of September 30, 2016, the fair value of the warrants was determined to be $3,648,243, resulting in an unrealized gain (loss) on the change in the fair value of this derivative liability of $351,055 and $(2,990,096) for the three and nine months ended September 30, 2016, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The following are the Company&#8217;s assets and liabilities, measured at fair value on a recurring basis, as of September 30, 2016 and December&#160;31, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair Value</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Fair Value</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Hierarchy</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Assets</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="68%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Marketable securities, September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="12%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,600</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14%; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="14%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 1</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Marketable securities, December 31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,600</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 1</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Liabilities</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Derivative Liability , September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,648,243</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 3</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Derivative Liability , December 31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 439,361</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Level 3</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Recent Accounting Pronouncements</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>NOTE 2: MANAGEMENT LIQUIDITY PLANS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 30, 2016, the Company had cash of $1,494,513&#160;and working capital deficit of $2,742,006, principally due to the inclusion of non-cash derivative liability recorded in current liabilities. Excluding the derivative liability, the Company&#8217;s working capital would have been $906,237. In addition, the Company used actual net cash in operations of $1,711,819 during the nine months ended September 30, 2016.&#160;The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">In May 2016, the Company sold shares of common stock and warrants for net proceeds, after commissions and other costs, of approximately $1,579,082. &#160;It is anticipated that the proceeds from the sale of its common stock and warrants will provide the Company with cash sufficient to fund operations through May 2017.&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company expects that cash used in operations will decrease significantly over the next several years as the Company executes its business plan.&#160;In the event that the Company is not able to fully achieve its plan, the Company may need to raise additional funds through equity or debt financing. If the Company is unsuccessful in raising additional financing, it will need to reduce costs and operations in the future.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accordingly, the accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>NOTE 3: RELATED PARTY TRANSACTIONS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Dr. Carr Bettis, Executive Chairman and Chairman of Board of Directors</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 30, 2016 and December&#160;31, 2015, the Company owed Dr. Bettis $5,992 and $72,944 in accrued salary, respectively.&#160;In addition, AudioEye sub-leases an office for the Company&#8217;s CEO Todd Bankofier from Verus Analytics, Inc, a company in which Dr. Bettis has a controlling interest in. The sub-lease amount is $500 per month totaling $1,500 and $4,500 in three and nine months ended September 30, 2016.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Sean Bradley, President, Chief Technology Officer, and Secretary</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 30, 2016 and December&#160;31, 2015, the Company owed Sean Bradley $8,752 and $6,250 in accrued salary, respectively.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>David Moradi, a Material Shareholder, on a fully diluted basis</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of December 31, 2015 the Company owed David Moradi $70,000 in principal and $4,280 in accrued interest. During the nine months ended September 30, 2016, Mr. Moradi <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">was paid in full. As of September 30, 2016, Mr. Moradi is no longer considered a material shareholder.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In summary, as of September 30, 2016 and December 31, 2015 the total balances of related party payables were $14,744 and $153,474, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 9 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>NOTE 6: STOCKHOLDERS&#8217; EQUITY</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 30, 2016 and December&#160;31, 2015, the Company had 107,458,430 and 81,717,154 shares of common stock issued and outstanding, respectively, and the Company had 160,000 and 175,000 shares of Series A Convertible Preferred Stock, respectively, issued at $10 per share, paying a 5% cumulative annual dividend and convertible at 0.1754 per share of common stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In April 2016, the Company issued an aggregate 83,336 shares of its common stock in payment for consulting services at a fair value of $14,292.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In April 2016, the Company issued an aggregate of 12,834,800 shares of its common stock to Note holders in settlement of $1,025,000 in convertible notes and accrued interest (Note 5).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In May 2016, the Company sold an aggregate of 11,714,285 shares of common stock of the Company and 1,312,000 warrants to purchase the Company&#8217;s common stock to accredited investors for net proceeds of $1,579,082.&#160; The warrants have a term of five years, an exercise price of $0.25 per share and are subject to anti-dilution protection, as defined.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In May 2016, the Company issued 900,525 shares of its common stock upon conversion of 15,000 shares of Series A Convertible Preferred Stock and accrued dividends.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In July 2016, the Company issued an aggregate 124,998 shares of its common stock in payment for consulting services at a fair value of $20,666.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In August 2016, the Company issued an aggregate 41,666 shares of its common stock in payment for consulting services at a fair value of $6,208.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>&#160;</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In September 2016, the Company issued an aggregate 41,666 shares of its common stock in payment for consulting services at a fair value of $6,292.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>&#160;</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Registration rights</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Under the purchase agreement, the Company has agreed to use its reasonable best efforts to prepare and file with the SEC registration statement within 60 days of the initial closing date, covering the resale by the investors of any common stock previously issued to the investors, and any common stock into which any convertible promissory notes previously issued to the investors are convertible and any common stock for which the warrants or any warrants previously issued to the investors are exercisable. The Company filed a registration statement on September 30, 2016.&#160;</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">NOTE 7: OPTIONS</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">As of September 30, 2016 and December&#160;31, 2015, the Company has outstanding options to purchase 25,005,504 and 14,759,914 shares of common stock, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Intrinsic</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Wtd&#160;Avg.</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Value</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Number&#160;of</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Wtd&#160;Avg.</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Remaining</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">of Exercisable</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Options</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercise&#160;Price</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Term</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercisable</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Options</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 35%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="35%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Outstanding at December&#160;31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14,759,914</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.30</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.61</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8,374,294</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#151;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Granted</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,756,090</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.08</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.86</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#151;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Forfeited/Expired</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> (510,500</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> )</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.78</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#151;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Outstanding at September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25,005,504</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.20</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.52</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 13,177,211</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 417,857</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On January 15, 2016, the Company granted performance options to acquire shares of the Company&#8217;s common stock in aggregate of 6,500,000 to key board member and officers at an exercise price of $0.038 per share for five years. Vesting shall only occur if the closing share price of the Company&#8217;s common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition). Of the granted options, 5,500,000 include performance conditions (as defined) with both conditions (market and performance) to be met before vesting. All determinations of whether performance goals have been achieved, the number of vested performance options earned by the grantee, and all other matters related to the award of performance options shall be made by the compensation committee of the Company&#8217;s board of directors in its sole discretion.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The estimated fair values of the options with performance and market conditions were determined using a Monte Carlo pricing model. Significant assumptions used in the valuation include expected term of 5 years, expected volatility of 162%, risk free interest rate of 1.46%, and expected dividend yield of 0%.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Nonperformance option grants during the nine months ended September 30, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 to 3.5 years, expected volatility of 102.00% to 174.99%, risk free interest rate of 0.87% to 1.73%, and expected dividend yield of 0%.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On April 15, 2016, the Company issued 49,715 options, which vest immediately, have an exercise price of $0.179, and expire on April 15, 2019. The value on the grant date of the options was $6,250.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On May 12, 2016, the Company issued 100,000 options, which vest 50% after one year and 4.17% every month thereafter, have an exercise price of $0.177, and expire on May 12, 2021. The value on the grant date of the options was $16,694.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On May 12, 2016, the Company issued an aggregate of 3,400,000 options, which vest 50% immediately and 50% vesting quarterly over 12 months, have an exercise price of $0.177, and expire on May 12, 2021. The value on the grant date of the options was $559,603.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On July 15, 2016, the Company issued 56,375 options, which vest immediately, have an exercise price of $0.156, and expire on July 15, 2019. The value on the grant date of the options was $6,250.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">For the three and nine months ended September&#160;30, 2016 and 2015, total stock compensation expense related to the options totaled $166,111 and $706,230 and $(119,224) and $709,311, respectively.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">As of September 30, 2016 and December&#160;31, 2015, the Company has outstanding options to purchase 25,005,504 and 14,759,914 shares of common stock, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Intrinsic</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Wtd&#160;Avg.</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Value</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Number&#160;of</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Wtd&#160;Avg.</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Remaining</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">of Exercisable</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Options</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercise&#160;Price</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Term</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercisable</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Options</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 35%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="35%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Outstanding at December&#160;31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14,759,914</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.30</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.61</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8,374,294</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#151;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Granted</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,756,090</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.08</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.86</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#151;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Forfeited/Expired</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> (510,500</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> )</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.78</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#151;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Outstanding at September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25,005,504</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.20</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.52</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 13,177,211</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 417,857</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Below is a table summarizing the Company&#8217;s outstanding warrants as of September 30, 2016 and December&#160;31, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Intrinsic</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Wtd&#160;Avg.</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Value</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Number&#160;of</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Wtd&#160;Avg.</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Remaining</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">of Exercisable</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Warrants</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercise&#160;Price</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Term</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercisable</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Warrants</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 35%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="35%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Outstanding at December&#160;31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 42,526,609</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.22</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.15</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 41,297,920</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,167</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercised</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> -</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Granted</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,961,513</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.02</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.66</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> -</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Expired</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> (393,081</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> )</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.42</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Outstanding at September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 64,095,041</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.15</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.73</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 63,907,541</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,059,950</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">NOTE 8: WARRANTS</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Below is a table summarizing the Company&#8217;s outstanding warrants as of September 30, 2016 and December&#160;31, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Intrinsic</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Wtd&#160;Avg.</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Value</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Number&#160;of</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Wtd&#160;Avg.</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Remaining</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">of Exercisable</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Warrants</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercise&#160;Price</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Term</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercisable</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Warrants</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 35%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="35%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Outstanding at December&#160;31, 2015</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 42,526,609</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.22</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.15</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 41,297,920</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="10%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,167</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Exercised</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> -</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Granted</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,961,513</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.02</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.66</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> -</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Expired</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> (393,081</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> )</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.42</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Outstanding at September 30, 2016</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 64,095,041</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.15</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.73</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 63,907,541</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,059,950</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The warrant grants during the nine months ended September 30, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 to 2.5 years, expected volatility of 166.74% to 178.98%, risk free interest rate of 0.71% to 1.08%, and expected dividend yield of 0%.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">During the nine months ended September 30, 2016, the Company issued an aggregate of 1,575,954 warrants to purchase shares of the Company&#8217;s common stock with an exercise prices of $0.038 to $0.179 per share vested immediately for services. The fair value on the grant date of the warrants was $150,500.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In April 2016, the Company issued an aggregate of 18,353,310 warrants to acquire its common stock in settlement of $1,541,678 convertible notes and accrued interest. The warrants issued to Anthion are exercisable at $0.001 per share for five years from the date of issuance.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company determined that the estimated fair value of the 18,353,311 warrants of $3,205,959 exceeded the settlement of $1,541,678 of convertible notes and accrued interest and accordingly recorded a loss of settlement of debt of $1,664,281 for the nine months ended September 30, 2016. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the warrants at settlement with the following assumptions: the price of the Company stock of $0.175, volatility was estimated to be 178%, the risk free rate of 1.24% and the remaining term was 5 years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In May 2016, the Company issued 1,312,000 warrants with an exercise price of $0.25 in connection with the sale of Common Stock. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.25 per share.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">For the three and nine months ended September&#160;30, 2016 and 2015, the Company has incurred warrant-based expense of $58,599 and $206,772 and $20,962 and $491,148, respectively.&#160;</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">NOTE 9: COMMITMENTS AND CONTINGENCIES</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">&#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">Litigation</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In April&#160;2015, two shareholder class action lawsuits were filed against the Company and former officers Nathaniel Bradley and Edward O&#8217;Donnell in the U.S. District Court for the District of Arizona. The plaintiffs allege various causes of action against the defendants arising from our announcement that our previously issued financial results for the first three quarters of 2014 and the guidance for the fourth quarter of 2014 and the full year of 2014 could no longer be relied upon.&#160; The complaints sought among other relief, compensatory damages and plaintiff&#8217;s counsel&#8217;s fees and experts&#8217; fees. The&#160;Court appointed a lead plaintiff and lead counsel, and&#160;consolidated the actions. A consolidated amended complaint was filed under the caption <i>In re&#160;AudioEye, Inc. Sec.&#160;Litigation.</i> The Company and individual defendants filed a motion to dismiss.&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On July 25, 2016, in connection with a voluntary mediation, the parties reached an agreement in principle to settle the consolidated actions.&#160;The settlement agreement is subject to definitive documentation, shareholder notice, and court approval. The terms of the agreement include a settlement payment to the class of $1,525,000 from the Company&#8217;s insurer, with no admission of liability by any party. In 2015, the Company paid a deductible under its&#160;D&amp;O insurance policy in the amount of $100,000 regarding this matter.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On May 16, 2016, a shareholder derivative complaint entitled&#160;<i>LiPoChing, Derivatively and on Behalf of&#160;AudioEye, Inc., v. Bradley, et al.</i>, was filed in the United States District Court for the District of Arizona. As a derivative complaint, the plaintiff-shareholder purports to act on behalf of&#160;the Company&#160;against certain of the Company's current and former officers and directors (the &#8220;<b><i>Named Individuals</i></b>&#8221;).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company is named as a nominal defendant. The complaint asserts causes of action including breach of fiduciary duty and others, arising from the Company&#8217;s restatement of its financial results for the first three quarters of 2014. The complaint seeks, among other relief, compensatory damages, restitution and attorneys&#8217; fees. No discovery has occurred. In October 2016, the Company and Named Defendants filed a motion to dismiss, which remains pending. While the Company believes that its legal defense costs may be reimbursed by the Company&#8217;s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;On July 26, 2016, a shareholder derivative complaint entitled&#160;<i>Denese&#160;M. Hebert, derivatively on Behalf of Nominal Defendant&#160;AudioEye, Inc., v. Bradley, et al.</i>, was filed in the State of Arizona Superior Court for Pima County. The complaint generally asserts causes of action related to the Company&#8217;s restatement of its financial statements for the first three fiscal quarters of 2014. &#160;As a derivative complaint, the plaintiff-shareholder purports to act on behalf of the Company&#160;against certain of the Company's current and former officers and directors (the &#8220;<i>Named Individuals</i>&#8221;). The Company is named as a nominal defendant. The Company understands that the Named Individuals intend to vigorously defend the lawsuit. While the Company believes that its legal defense costs may be reimbursed by the Company&#8217;s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We may become involved in various other routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1525000 100000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">NOTE 4: INTANGIBLE ASSETS</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">For the nine months ended September 30, 2016 and 2015, the Company invested in Patents in the amounts of $42,007 and $88,156 respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Prior to December&#160;31, 2015, patents, technology and other intangibles with contractual terms were generally amortized over their estimated useful lives of ten years. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Software development costs are amortized over their estimated useful life of three years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Prior to any impairment adjustment, intangible assets consisted of the following:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">September 30,</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">December 31,</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2016</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2015</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="68%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Patents</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="12%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,697,076</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="12%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,655,069</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Capitalized software development</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 621,567</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 621,567</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Accumulated amortization</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> (1,864,481</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> )</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> (1,435,780</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> )</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Intangible assets, net</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,454,162</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,840,856</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Amortization expense for patents totaled $94,209 and $281,064 for the three and nine months ended September 30, 2016, respectively; and $87,395 and $268,940 for the three and nine months ended September 30, 2015, respectively. Amortization expense for software development totaled $56,119 and $147,637 for the three and nine months ended September 30, 2016, respectively; and $40,427 and $126,677 for the three and nine months ended September 30, 2015, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Total amortization expense totaled $428,701 and $395,617 for the nine months ended September 30, 2016 and 2015, respectively.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Prior to any impairment adjustment, intangible assets consisted of the following:</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <table style="clear:both;BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">September 30,</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">December 31,</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2016</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" colspan="2"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2015</font></b></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></b></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="68%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Patents</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="12%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,697,076</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="2%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="12%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,655,069</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom" width="1%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Capitalized software development</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 621,567</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 621,567</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Accumulated amortization</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> (1,864,481</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> )</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> (1,435,780</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> )</font></div> </td> </tr> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Intangible assets, net</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,454,162</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font></div> </td> <td style="BORDER-BOTTOM: black 1pt solid; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,840,856</font></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BACKGROUND: white; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="bottom"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> EX-101.SCH 5 aeye-20160930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 106 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - MANAGEMENT LIQUIDITY PLANS link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - NOTES PAYABLE link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - OPTIONS link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - WARRANTS link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Policies) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Tables) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - OPTIONS (Tables) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - WARRANTS (Tables) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - MANAGEMENT LIQUIDITY PLANS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - RELATED PARTY TRANSACTIONS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - INTANGIBLE ASSETS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - NOTES PAYABLE (Details Textual) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - STOCKHOLDERS' EQUITY (Details Textual) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - OPTIONS (Details) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - OPTIONS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - WARRANTS (Details) link:presentationLink link:definitionLink link:calculationLink 136 - Disclosure - WARRANTS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 137 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Textual) link:presentationLink link:definitionLink link:calculationLink 138 - Disclosure - SUBSEQUENT EVENTS (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 aeye-20160930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 aeye-20160930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 aeye-20160930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 9 aeye-20160930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 10 image_001.jpg GRAPHIC begin 644 image_001.jpg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end XML 11 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2016
Nov. 14, 2016
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2016  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q3  
Entity Registrant Name AUDIOEYE INC  
Entity Central Index Key 0001362190  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol AEYE  
Entity Common Stock, Shares Outstanding   107,500,096
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash $ 1,494,513 $ 1,687,257
Accounts receivable, net 20,499 22,741
Marketable securities, held in related party 3,600 3,600
Non-marketable securities, held in related party 50,000 50,000
Prepaid expenses and other current assets 57,828 41,388
Total current assets 1,626,440 1,804,986
Intangible assets, net 2,454,162 2,840,856
Goodwill 700,528 700,528
Total assets 4,781,130 5,346,370
Current liabilities:    
Accounts payable and accrued expenses 267,377 213,620
Notes and loans payable, current 24,000 24,000
Related party payables 14,744 153,474
Derivative liabilities 3,648,243 439,361
Deferred revenue 414,082 60,790
Total current liabilities 4,368,446 891,245
Long term liabilities:    
Convertible notes and loans payable, net 5,800 1,923,499
Total liabilities 4,374,246 2,814,744
Stockholders' equity:    
Preferred stock, $0.00001 par value, 10,000,000 shares authorized, 160,000 and 175,000 issued and outstanding as of September 30, 2016 and December 31, 2015, respectively 2 2
Common stock, $0.00001 par value, 250,000,000 shares authorized, 107,458,430 and 81,717,154 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively 1,074 817
Treasury stock (623,000) (623,000)
Additional paid in capital 33,997,819 27,393,238
Accumulated deficit (32,969,011) (24,239,431)
Total stockholders' equity 406,884 2,531,626
Total liabilities and stockholders' equity $ 4,781,130 $ 5,346,370
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2016
Dec. 31, 2015
Preferred Stock, Par or Stated Value Per Share $ 0.00001 $ 0.00001
Preferred Stock, Shares Authorized 10,000,000 10,000,000
Preferred Stock, Shares Issued 160,000 175,000
Preferred Stock, Shares Outstanding 160,000 175,000
Common Stock, Par or Stated Value Per Share $ 0.00001 $ 0.00001
Common Stock, Shares Authorized 250,000,000 250,000,000
Common Stock, Shares, Issued 107,458,430 81,717,154
Common Stock, Shares, Outstanding 107,458,430 81,717,154
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues $ 282,676 $ 108,685 $ 594,237 $ 314,146
Cost of revenue 311,519 321,755 904,091 1,178,388
Gross Loss (28,843) (213,070) (309,854) (864,242)
Operating expenses:        
Selling and marketing 192,881 171,594 510,448 747,990
Research and development 85,192 92,857 255,805 293,877
General and administrative 602,041 (27,278) 1,894,964 4,161,269
Amortization and depreciation 150,328 128,381 428,701 396,269
Total operating expenses 1,030,442 365,554 3,089,918 5,599,405
Operating loss (1,059,285) (578,624) (3,399,772) (6,463,647)
Other income (expense):        
Unrealized gain (loss) on derivative liabilities 351,055 0 (2,990,096) 0
Unrealized gain on marketable securities 900 0 0 0
Loss on settlement of debt 0 0 (1,664,281) 0
Other income 0 0 750 0
Interest income (expense) 266 81 (676,181) 3,345
Total other income (expense) 352,221 81 (5,329,808) 3,345
Net loss (707,064) (578,543) (8,729,580) (6,460,302)
Preferred stock dividend (20,000) 0 (60,000) (594,641)
Net loss available to common stockholders $ (727,064) $ (578,543) $ (8,789,580) $ (7,054,943)
Net loss per common share-basic and diluted (in dollars per share) $ (0.01) $ (0.01) $ (0.09) $ (0.09)
Weighted average common shares outstanding-basic and diluted (in shares) 107,382,344 81,800,488 95,840,596 80,007,507
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - 9 months ended Sep. 30, 2016 - USD ($)
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Balance at Dec. 31, 2015 $ 2,531,626 $ 817 $ 2 $ 27,393,238 $ (623,000) $ (24,239,431)
Balance (in shares) at Dec. 31, 2015   81,717,154 175,000      
Common stock issued for services 47,458 $ 3 $ 0 47,455 0 0
Common stock issued for services (in shares)   291,666 0      
Common stock issued in settlement of convertible notes and accrued interest 1,078,123 $ 128 $ 0 1,077,995 0 0
Common stock issued in settlement of convertible notes and accrued interest (in shares)   12,834,800 0      
Common stock and warrants issued for cash, net of placement costs of $60,918 1,579,082 $ 117 $ 0 1,578,965 0 0
Common stock and warrants issued for cash, net of placement costs of $60,918 (in shares)   11,714,285 0      
Common stock issued upon conversion of preferred stock 0 $ 9 $ 0 (9) 0 0
Common stock issued upon conversion of preferred stock (in shares)   900,525 (15,000)      
Fair value of warrants issued in settlement of convertible debt and accrued interest 3,205,959 $ 0 $ 0 3,205,959 0 0
Reclassify fair value of liability warrants issued in connection with sale of common stock (218,786) 0 0 (218,786) 0 0
Warrants and Options issued for services 913,002 0 0 913,002 0 0
Net loss (8,729,580) 0 0 0 0 (8,729,580)
Balance at Sep. 30, 2016 $ 406,884 $ 1,074 $ 2 $ 33,997,819 $ (623,000) $ (32,969,011)
Balance (in shares) at Sep. 30, 2016   107,458,430 160,000      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical)
9 Months Ended
Sep. 30, 2016
USD ($)
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs $ 60,918
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (8,729,580) $ (6,460,302)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 428,701 396,269
Amortization of debt discounts 600,301 0
Option, warrant and PSU expense 913,002 1,200,459
Stock issued or issuable for services 47,458 679,972
Loss on change in derivative liabilities 2,990,096 0
Loss on settlement of debt 1,664,281 0
Changes in operating assets and liabilities:    
Accounts receivable 2,242 212,662
Related party receivable 0 (44,250)
Other current assets (16,440) 11,650
Accounts payable and accruals 173,558 (517,743)
Billing in excess of costs 0 (57,012)
Deferred revenue 353,292 0
Related party payables (138,730) (226,483)
Net cash (used in) operating activities (1,711,819) (4,804,778)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Cash (paid for) intellectual property (42,007) (88,156)
Net cash (used in) investing activities (42,007) (88,156)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Issuance of common stock and warrants for cash 1,579,082 325,000
Collection of stock subscription receivable 0 1,175,000
Issuance of preferred stock for cash 0 1,750,000
Proceeds from exercise of options and warrants 0 43,943
Repayments of notes payable (18,000) (22,000)
Net cash provided by financing activities 1,561,082 3,271,943
Net decrease in cash (192,744) (1,620,991)
Cash-beginning of period 1,687,257 1,672,901
Cash-end of period 1,494,513 51,910
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Interest paid 0 307
Income taxes paid 0 0
Non-cash investing and financing activities:    
Deemed dividend beneficial conversion feature on convertible preferred stock 0 594,641
Common stock issued in settlement of convertible notes payable and accrued interest 1,078,123 0
Fair value of warrants issued in settlement of convertible notes payable and accrued interest 3,205,959 0
Reclass fair value of liability warrants from equity to liability upon issuance 218,786 0
Common stock issued on conversion of preferred stock $ 9 $ 0
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
ORGANIZATION AND BASIS OF PRESENTATION
9 Months Ended
Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION
 
The accompanying unaudited interim financial statements of AudioEye, Inc. and its wholly-owned subsidiary (collectively, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2016.
 
In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended December 31, 2015 as reported in the Company’s Annual Report on Form 10-K have been omitted.
 
Corporate Information and Background
 
AudioEye, Inc. was formed as a Delaware corporation on May 20, 2005. The Company focuses on providing its customers with the most complete and inclusive web accessibility solution available. The Company’s suite of technologies allows its customers to provide their site visitors with an enhanced web experience. When implemented, the Company believes its solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty. In addition, the Company’s solutions provide organizations with the ability to comply with internationally accepted web content accessibility guidelines (WCAG) as well as United States, Canadian and United Kingdom accessibility laws.
 
Reclassification
 
Certain prior year amounts have been reclassified to conform to the current year presentation.
 
Revenue Recognition
 
Revenue is recognized when all applicable recognition criteria have been met, which generally include (a) persuasive evidence of an existing arrangement; (b) fixed or determinable price; (c) delivery has occurred or service has been rendered; and (d) collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a) estimate of total hours and milestones to complete; (b) total hours completed; (c) delivery of services rendered; (d) change in estimates; and (e) collectability of the contract.
 
The Company had one major customer including their affiliates which generated approximately 55% of its revenue in the three months ended September 30, 2016.
 
The Company had four major customers including their affiliates which generated approximately 43% (21%, 16%, 15% and 11%) of its revenue in the nine months ended September 30, 2016.
 
At September 30, 2016, the Company had three customers representing 24%, 17% and 15% of the outstanding accounts receivable.
 
Certain Software as a Service (SaaS) and website hosting contracts are prepared and invoiced on an annual basis. Any funds received for hosting services not provided yet are held in deferred revenue, and are recorded as revenue when earned.
 
Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.
 
Stock based compensation
 
The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash.
 
Derivative Instrument Liability
 
The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At September 30, 2016 and December 31, 2015, the Company did not have any derivative instruments that were designated as hedges.
 
On October 9, 2015, the Company issued convertible promissory notes representing $2,500,000 in aggregate principal together with warrants exercisable for up to 25,000,000 shares of Common Stock. The warrants have a strike price of $0.10 and term of 5 years. In addition on May 9, 2016, in connection with the sale of the Company’s common stock, the Company issued warrants exercisable for up to 1,312,000 shares of Common Stock. The warrants have a strike price of $0.25 and a term of 5 years.
 
In accordance with ASC 815, these outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheets. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the “operating activities” of the Consolidated Statements of Cash Flow. At September 30, 2016 and December 31, 2015, the derivative liability was stated at $3,648,243 and $439,361, respectively. The change in fair value of $2,990,096 was driven by the increased value of the Company’s common stock in the period and recorded as the “Loss on change in derivative liability” in the Consolidated Statements of Operations for the nine months ended September 30, 2016. As the warrants are exercised or expire, the derivative liability will be adjusted on the balance sheet and an adjustment will be reflected in stockholders equity under additional paid-in capital.
 
Fair Value Measurements
 
Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels: 
 
Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.
 
Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.
 
Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.
 
An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.
 
In October and November 2015, the Company issued warrants with an exercise price of $0.10 in connection with a convertible debt instruments. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.10 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.
 
The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.031 to $0.058, volatility was estimated to be 102%, the risk free rate ranged 1.14% to 1.75% and the remaining term was 5 years.
 
In April and May 2016, the Company issued warrants with an exercise price of $0.25 in connection with the sale of Common Stock. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.25 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.
 
The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.169 to $0.195, volatility was estimated to be from 169% to 178%, the risk free rate ranged 1.22% to 1.35% and the remaining term was 5 years. The estimated initial fair value of these warrants of $218,786 was reclassified from equity to liability at the date of issuance.
 
At September 30, 2016, the price of the Company stock was 0.149, volatility was estimated to be 170.52%, the risk free rate of 1.14% and the remaining term ranged from 4.02 to 4.56 years. As of September 30, 2016, the fair value of the warrants was determined to be $3,648,243, resulting in an unrealized gain (loss) on the change in the fair value of this derivative liability of $351,055 and $(2,990,096) for the three and nine months ended September 30, 2016, respectively.
 
The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of September 30, 2016 and December 31, 2015:
 
 
 
 
 
 
Fair Value
 
 
Fair Value
 
 
Hierarchy
Assets
 
 
 
 
 
 
Marketable securities, September 30, 2016
 
$
3,600
 
 
Level 1
Marketable securities, December 31, 2015
 
$
3,600
 
 
Level 1
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
Derivative Liability , September 30, 2016
 
$
3,648,243
 
 
Level 3
Derivative Liability , December 31, 2015
 
$
439,361
 
 
Level 3
 
Recent Accounting Pronouncements
 
There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
MANAGEMENT LIQUIDITY PLANS
9 Months Ended
Sep. 30, 2016
Going Concern [Abstract]  
Substantial Doubt about Going Concern [Text Block]
NOTE 2: MANAGEMENT LIQUIDITY PLANS
 
As of September 30, 2016, the Company had cash of $1,494,513 and working capital deficit of $2,742,006, principally due to the inclusion of non-cash derivative liability recorded in current liabilities. Excluding the derivative liability, the Company’s working capital would have been $906,237. In addition, the Company used actual net cash in operations of $1,711,819 during the nine months ended September 30, 2016. The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
 
In May 2016, the Company sold shares of common stock and warrants for net proceeds, after commissions and other costs, of approximately $1,579,082.  It is anticipated that the proceeds from the sale of its common stock and warrants will provide the Company with cash sufficient to fund operations through May 2017. 
 
The Company expects that cash used in operations will decrease significantly over the next several years as the Company executes its business plan. In the event that the Company is not able to fully achieve its plan, the Company may need to raise additional funds through equity or debt financing. If the Company is unsuccessful in raising additional financing, it will need to reduce costs and operations in the future.
 
Accordingly, the accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2016
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
NOTE 3: RELATED PARTY TRANSACTIONS
 
Dr. Carr Bettis, Executive Chairman and Chairman of Board of Directors
 
As of September 30, 2016 and December 31, 2015, the Company owed Dr. Bettis $5,992 and $72,944 in accrued salary, respectively. In addition, AudioEye sub-leases an office for the Company’s CEO Todd Bankofier from Verus Analytics, Inc, a company in which Dr. Bettis has a controlling interest in. The sub-lease amount is $500 per month totaling $1,500 and $4,500 in three and nine months ended September 30, 2016.
 
Sean Bradley, President, Chief Technology Officer, and Secretary
 
As of September 30, 2016 and December 31, 2015, the Company owed Sean Bradley $8,752 and $6,250 in accrued salary, respectively.
 
David Moradi, a Material Shareholder, on a fully diluted basis
 
As of December 31, 2015 the Company owed David Moradi $70,000 in principal and $4,280 in accrued interest. During the nine months ended September 30, 2016, Mr. Moradi was paid in full. As of September 30, 2016, Mr. Moradi is no longer considered a material shareholder.
 
In summary, as of September 30, 2016 and December 31, 2015 the total balances of related party payables were $14,744 and $153,474, respectively.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
INTANGIBLE ASSETS
9 Months Ended
Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure [Text Block]
NOTE 4: INTANGIBLE ASSETS
 
For the nine months ended September 30, 2016 and 2015, the Company invested in Patents in the amounts of $42,007 and $88,156 respectively.
 
Prior to December 31, 2015, patents, technology and other intangibles with contractual terms were generally amortized over their estimated useful lives of ten years. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted.
 
Software development costs are amortized over their estimated useful life of three years.
 
Prior to any impairment adjustment, intangible assets consisted of the following:
 
 
 
September 30,
 
 
December 31,
 
 
 
2016
 
 
2015
 
Patents
 
$
3,697,076
 
 
$
3,655,069
 
Capitalized software development
 
 
621,567
 
 
 
621,567
 
Accumulated amortization
 
 
(1,864,481
)
 
 
(1,435,780
)
Intangible assets, net
 
$
2,454,162
 
 
$
2,840,856
 
 
Amortization expense for patents totaled $94,209 and $281,064 for the three and nine months ended September 30, 2016, respectively; and $87,395 and $268,940 for the three and nine months ended September 30, 2015, respectively. Amortization expense for software development totaled $56,119 and $147,637 for the three and nine months ended September 30, 2016, respectively; and $40,427 and $126,677 for the three and nine months ended September 30, 2015, respectively.
 
Total amortization expense totaled $428,701 and $395,617 for the nine months ended September 30, 2016 and 2015, respectively.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
NOTES PAYABLE
9 Months Ended
Sep. 30, 2016
Notes Payable [Abstract]  
Debt Disclosure [Text Block]
NOTE 5: NOTES PAYABLE
 
As of September 30, 2016 and December 31, 2015, the Company has short term and long term notes payable of $24,000 and $5,800, and $24,000 and $1,923,499, respectively as shown in the table below.
 
Notes and loans payable
 
September 30,
2016
 
 
December 31,
2015
 
Short Term
 
 
 
 
 
 
 
 
Maryland TEDCO
 
$
24,000
 
 
$
24,000
 
Total
 
$
24,000
 
 
$
24,000
 
Long Term
 
 
 
 
 
 
 
 
Convertible Secured Note (net of unamortized discounts of $600,301 in 2015)
 
 
-
 
 
 
1,899,699
 
Maryland TEDCO
 
$
5,800
 
 
$
23,800
 
Total
 
$
5,800
 
 
$
1,923,499
 
 
As of December 31, 2012, the Company had an outstanding loan to a third party in the amount of $74,900, which was originally issued during 2006 as part of an Investment Agreement. The loan was unsecured and bore interest at 25% per year for four years. The Company had accrued interest of $74,900, which was included in accounts payable and accrued expenses on the consolidated balance sheets.  The note was in default until October 24, 2011, at which time the Company entered into a Termination and Release Agreement (“Release”) with the third party.  The terms of the Release, among other things, terminated the Investment Agreement between the parties, and required the Company to issue a Promissory Note to the third-party in the combined amount of principal and accrued interest to date, for a total principal amount of $149,800.  The note is interest free, and is payable in monthly installments of $2,000 beginning November 1, 2011.  As of September 30, 2016 and December 31, 2015, the principal amount owing was $29,800 and $47,800, respectively, of which $24,000 and $24,000, respectively, has been recorded as the current portion of the note, and $5,800 and $23,800, respectively, as the long-term portion of the note. The Company has paid $18,000 for the nine months ended September 30, 2016.
 
On October 9, 2015 (the “Initial Closing Date”), AudioEye, Inc. (the “Company”) entered into a Note and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”) for the issuance and sale of convertible promissory notes in an aggregate principal amount of up to $3,750,000 (the “Notes”) and warrants (the “Warrants”) to purchase up to an aggregate of 37,500,000 shares of common stock of the Company (the “Common Stock”) (the “Transaction”). Notes representing up to $2,500,000 in aggregate principal, and Warrants exercisable for up to 25,000,000 shares of Common Stock in the aggregate, may be issued and sold at one or more closings during the 30-day period immediately following the Initial Closing Date. The maximum of $2,500,000 in aggregate principal was sold as of November 8, 2015. In addition, upon the election of any Investor within the three-year period immediately following the Initial Closing Date, any Investor may purchase an additional Note in the principal amount equal to 50% of the principal amount of the Notes purchased by such Investor at previous closings (the “Option Principal Amount”) and an additional Warrant with an aggregate exercise price equal to such Investor’s Option Principal Amount.
 
The Notes mature three years from the date of issuance (the “Maturity Date”) and, until the Notes are repaid or converted into shares of the Company’s equity securities (“Equity Securities”), accrue payable-in-kind interest at the rate of 10% per annum. As described in the Purchase Agreement, as amended (see below), if the Company sold Equity Securities in a single transaction or series of related transactions for cash of at least $1,000,000 (excluding the conversion of the Notes and excluding the shares of Common Stock to be issued upon exercise of the Warrants) on or before the Maturity Date (the “Equity Financing”), all of the unpaid principal on the Notes plus accrued interest shall be automatically converted at the closing of the Equity Financing into a number of shares of the same class or series of Equity Securities as are issued and sold by the Company in such Equity Financing (or a class or series of Equity Securities identical in all respects to and ranking pari passu with the class or series of Equity Securities issued and sold in such Equity Financing) as is determined by dividing (i) the principal and accrued and unpaid interest amount of the Notes by (ii) 60% of the price per share at which such Equity Securities are issued and sold in such Equity Financing. The Notes, if not converted, shall be due and payable in full on the Maturity Date.
 
The Notes contained customary events of default provisions. In connection with the issuance of the Notes, on October 9, 2015, the Company entered into a Security Agreement with the Investors (the “Security Agreement”) pursuant to which the Company granted a security interest in all of its assets to the Investors as collateral for the Company’s obligations under the Notes. As noted below, on April 18, 2016, the parties agreed to remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement.
 
The Warrants are exercisable at $0.10 per share and expire 60 months following the date of issuance. The Warrants are subject to anti-dilution protection, subject to certain customary exceptions.
 
During 2015, the Company issued notes under this offering totaling $2,500,000. The fair value of the warrants issued in connection with the notes was determined to be $627,293 and was recognized as a discount to the debt being amortized to interest expense over the life of the loans. During three and nine months ended September 30, 2016, aggregate amortization (and write-off) of $-0- and $600,301 was recognized against the discount.
 
In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the “Purchase Agreement Amendment”) and an Omnibus Amendment to Secured Promissory Notes (the “Note Amendment”), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the “Original Agreement”) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, “Anthion”) to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of “qualified financing” under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing “blocker” provisions (“Special Warrants”) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar “blocker” provisions.
 
On April 18, 2016, the Company issued an aggregate of 12,834,800 shares of its common stock to the Note holders other than Anthion, and 18,353,310 warrants to acquire its common stock to Anthion in lieu of common stock. Collectively the common stock and warrants issued were in full settlement of $2,500,000 convertible notes and accrued interest of $119,801. The warrants issued to Anthion are exercisable at $0.001 per share for five years from the date of issuance.
 
At the date of conversion, the Company determined that the conversion price of $0.84 per share did not exceed the fair value of Common Stock at note inception, therefore there was no beneficial conversion feature upon conversion of $1,025,000 of convertible notes and accrued interest. However, the Company determined that the estimated fair value of the 18,353,310 warrants of $3,205,959 exceeded the settlement of $1,541,678 of convertible notes and accrued interest and accordingly recorded a loss of settlement of debt of $1,664,281 for the nine months ended September 30, 2016. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the warrants at the date of conversion using the following assumptions: the price of the Company stock of $0.175, volatility was estimated to be 178%, the risk free rate of 1.24% and the remaining term was 5 years.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
STOCKHOLDERS' EQUITY
9 Months Ended
Sep. 30, 2016
Stockholders' Equity Attributable to Parent [Abstract]  
Sale Leaseback Transaction Disclosure [Text Block]
NOTE 6: STOCKHOLDERS’ EQUITY
 
As of September 30, 2016 and December 31, 2015, the Company had 107,458,430 and 81,717,154 shares of common stock issued and outstanding, respectively, and the Company had 160,000 and 175,000 shares of Series A Convertible Preferred Stock, respectively, issued at $10 per share, paying a 5% cumulative annual dividend and convertible at 0.1754 per share of common stock.
 
In April 2016, the Company issued an aggregate 83,336 shares of its common stock in payment for consulting services at a fair value of $14,292.
 
In April 2016, the Company issued an aggregate of 12,834,800 shares of its common stock to Note holders in settlement of $1,025,000 in convertible notes and accrued interest (Note 5).
 
In May 2016, the Company sold an aggregate of 11,714,285 shares of common stock of the Company and 1,312,000 warrants to purchase the Company’s common stock to accredited investors for net proceeds of $1,579,082.  The warrants have a term of five years, an exercise price of $0.25 per share and are subject to anti-dilution protection, as defined.
 
In May 2016, the Company issued 900,525 shares of its common stock upon conversion of 15,000 shares of Series A Convertible Preferred Stock and accrued dividends.
 
In July 2016, the Company issued an aggregate 124,998 shares of its common stock in payment for consulting services at a fair value of $20,666.
 
In August 2016, the Company issued an aggregate 41,666 shares of its common stock in payment for consulting services at a fair value of $6,208.
 
In September 2016, the Company issued an aggregate 41,666 shares of its common stock in payment for consulting services at a fair value of $6,292.
 
Registration rights
 
Under the purchase agreement, the Company has agreed to use its reasonable best efforts to prepare and file with the SEC registration statement within 60 days of the initial closing date, covering the resale by the investors of any common stock previously issued to the investors, and any common stock into which any convertible promissory notes previously issued to the investors are convertible and any common stock for which the warrants or any warrants previously issued to the investors are exercisable. The Company filed a registration statement on September 30, 2016. 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
OPTIONS
9 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE 7: OPTIONS
 
As of September 30, 2016 and December 31, 2015, the Company has outstanding options to purchase 25,005,504 and 14,759,914 shares of common stock, respectively.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intrinsic
 
 
 
 
 
 
 
 
 
Wtd Avg.
 
 
 
 
 
Value
 
 
 
Number of
 
 
Wtd Avg.
 
 
Remaining
 
 
 
 
 
of Exercisable
 
 
 
Options
 
 
Exercise Price
 
 
Term
 
 
Exercisable
 
 
Options
 
Outstanding at December 31, 2015
 
 
14,759,914
 
 
$
0.30
 
 
 
3.61
 
 
 
8,374,294
 
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
10,756,090
 
 
 
0.08
 
 
 
4.86
 
 
 
 
 
 
 
 
Forfeited/Expired
 
 
(510,500
)
 
 
0.78
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at September 30, 2016
 
 
25,005,504
 
 
$
0.20
 
 
 
3.52
 
 
 
13,177,211
 
 
$
417,857
 
 
On January 15, 2016, the Company granted performance options to acquire shares of the Company’s common stock in aggregate of 6,500,000 to key board member and officers at an exercise price of $0.038 per share for five years. Vesting shall only occur if the closing share price of the Company’s common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition). Of the granted options, 5,500,000 include performance conditions (as defined) with both conditions (market and performance) to be met before vesting. All determinations of whether performance goals have been achieved, the number of vested performance options earned by the grantee, and all other matters related to the award of performance options shall be made by the compensation committee of the Company’s board of directors in its sole discretion.
 
The estimated fair values of the options with performance and market conditions were determined using a Monte Carlo pricing model. Significant assumptions used in the valuation include expected term of 5 years, expected volatility of 162%, risk free interest rate of 1.46%, and expected dividend yield of 0%.
 
Nonperformance option grants during the nine months ended September 30, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 to 3.5 years, expected volatility of 102.00% to 174.99%, risk free interest rate of 0.87% to 1.73%, and expected dividend yield of 0%.
 
On April 15, 2016, the Company issued 49,715 options, which vest immediately, have an exercise price of $0.179, and expire on April 15, 2019. The value on the grant date of the options was $6,250.
 
On May 12, 2016, the Company issued 100,000 options, which vest 50% after one year and 4.17% every month thereafter, have an exercise price of $0.177, and expire on May 12, 2021. The value on the grant date of the options was $16,694.
 
On May 12, 2016, the Company issued an aggregate of 3,400,000 options, which vest 50% immediately and 50% vesting quarterly over 12 months, have an exercise price of $0.177, and expire on May 12, 2021. The value on the grant date of the options was $559,603.
 
On July 15, 2016, the Company issued 56,375 options, which vest immediately, have an exercise price of $0.156, and expire on July 15, 2019. The value on the grant date of the options was $6,250.
 
For the three and nine months ended September 30, 2016 and 2015, total stock compensation expense related to the options totaled $166,111 and $706,230 and $(119,224) and $709,311, respectively.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
WARRANTS
9 Months Ended
Sep. 30, 2016
Warrants [Abstract]  
Warrants [Text Block]
NOTE 8: WARRANTS
 
Below is a table summarizing the Company’s outstanding warrants as of September 30, 2016 and December 31, 2015:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intrinsic
 
 
 
 
 
 
 
 
 
Wtd Avg.
 
 
 
 
 
Value
 
 
 
Number of
 
 
Wtd Avg.
 
 
Remaining
 
 
 
 
 
of Exercisable
 
 
 
Warrants
 
 
Exercise Price
 
 
Term
 
 
Exercisable
 
 
Warrants
 
Outstanding at December 31, 2015
 
 
42,526,609
 
 
$
0.22
 
 
 
4.15
 
 
 
41,297,920
 
 
$
1,167
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercised
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
21,961,513
 
 
 
0.02
 
 
 
4.66
 
 
 
 
 
 
 
-
 
Expired
 
 
(393,081
)
 
 
0.42
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at September 30, 2016
 
 
64,095,041
 
 
 
0.15
 
 
 
3.73
 
 
 
63,907,541
 
 
$
4,059,950
 
 
The warrant grants during the nine months ended September 30, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 to 2.5 years, expected volatility of 166.74% to 178.98%, risk free interest rate of 0.71% to 1.08%, and expected dividend yield of 0%.
 
During the nine months ended September 30, 2016, the Company issued an aggregate of 1,575,954 warrants to purchase shares of the Company’s common stock with an exercise prices of $0.038 to $0.179 per share vested immediately for services. The fair value on the grant date of the warrants was $150,500.
 
In April 2016, the Company issued an aggregate of 18,353,310 warrants to acquire its common stock in settlement of $1,541,678 convertible notes and accrued interest. The warrants issued to Anthion are exercisable at $0.001 per share for five years from the date of issuance.
 
The Company determined that the estimated fair value of the 18,353,311 warrants of $3,205,959 exceeded the settlement of $1,541,678 of convertible notes and accrued interest and accordingly recorded a loss of settlement of debt of $1,664,281 for the nine months ended September 30, 2016. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the warrants at settlement with the following assumptions: the price of the Company stock of $0.175, volatility was estimated to be 178%, the risk free rate of 1.24% and the remaining term was 5 years.
 
In May 2016, the Company issued 1,312,000 warrants with an exercise price of $0.25 in connection with the sale of Common Stock. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.25 per share.
 
For the three and nine months ended September 30, 2016 and 2015, the Company has incurred warrant-based expense of $58,599 and $206,772 and $20,962 and $491,148, respectively. 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
NOTE 9: COMMITMENTS AND CONTINGENCIES
 
Litigation
 
In April 2015, two shareholder class action lawsuits were filed against the Company and former officers Nathaniel Bradley and Edward O’Donnell in the U.S. District Court for the District of Arizona. The plaintiffs allege various causes of action against the defendants arising from our announcement that our previously issued financial results for the first three quarters of 2014 and the guidance for the fourth quarter of 2014 and the full year of 2014 could no longer be relied upon.  The complaints sought among other relief, compensatory damages and plaintiff’s counsel’s fees and experts’ fees. The Court appointed a lead plaintiff and lead counsel, and consolidated the actions. A consolidated amended complaint was filed under the caption In re AudioEye, Inc. Sec. Litigation. The Company and individual defendants filed a motion to dismiss. 
 
On July 25, 2016, in connection with a voluntary mediation, the parties reached an agreement in principle to settle the consolidated actions. The settlement agreement is subject to definitive documentation, shareholder notice, and court approval. The terms of the agreement include a settlement payment to the class of $1,525,000 from the Company’s insurer, with no admission of liability by any party. In 2015, the Company paid a deductible under its D&O insurance policy in the amount of $100,000 regarding this matter.
 
On May 16, 2016, a shareholder derivative complaint entitled LiPoChing, Derivatively and on Behalf of AudioEye, Inc., v. Bradley, et al., was filed in the United States District Court for the District of Arizona. As a derivative complaint, the plaintiff-shareholder purports to act on behalf of the Company against certain of the Company's current and former officers and directors (the “Named Individuals”).
 
The Company is named as a nominal defendant. The complaint asserts causes of action including breach of fiduciary duty and others, arising from the Company’s restatement of its financial results for the first three quarters of 2014. The complaint seeks, among other relief, compensatory damages, restitution and attorneys’ fees. No discovery has occurred. In October 2016, the Company and Named Defendants filed a motion to dismiss, which remains pending. While the Company believes that its legal defense costs may be reimbursed by the Company’s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement.
 
 On July 26, 2016, a shareholder derivative complaint entitled Denese M. Hebert, derivatively on Behalf of Nominal Defendant AudioEye, Inc., v. Bradley, et al., was filed in the State of Arizona Superior Court for Pima County. The complaint generally asserts causes of action related to the Company’s restatement of its financial statements for the first three fiscal quarters of 2014.  As a derivative complaint, the plaintiff-shareholder purports to act on behalf of the Company against certain of the Company's current and former officers and directors (the “Named Individuals”). The Company is named as a nominal defendant. The Company understands that the Named Individuals intend to vigorously defend the lawsuit. While the Company believes that its legal defense costs may be reimbursed by the Company’s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement.
 
We may become involved in various other routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2016
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
NOTE 10: SUBSEQUENT EVENTS
 
Employee options/warrants
 
On October 15, 2016, the Company granted 61,599 options to Sean Bradley as compensation for services rendered. The options are exercisable at $0.125 for three years, vesting immediately. The exercise price was determined using the 10-day average closing price beginning with the closing price on October 1, 2016.
 
Common stock
 
In October 2015, the Company issued 41,666 shares of its common stock for consulting services rendered valued at $4,292.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
ORGANIZATION AND BASIS OF PRESENTATION (Policies)
9 Months Ended
Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Accounting, Policy [Policy Text Block]
Corporate Information and Background
 
AudioEye, Inc. was formed as a Delaware corporation on May 20, 2005. The Company focuses on providing its customers with the most complete and inclusive web accessibility solution available. The Company’s suite of technologies allows its customers to provide their site visitors with an enhanced web experience. When implemented, the Company believes its solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty. In addition, the Company’s solutions provide organizations with the ability to comply with internationally accepted web content accessibility guidelines (WCAG) as well as United States, Canadian and United Kingdom accessibility laws.
Reclassification, Policy [Policy Text Block]
Reclassification
 
Certain prior year amounts have been reclassified to conform to the current year presentation.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
 
Revenue is recognized when all applicable recognition criteria have been met, which generally include (a) persuasive evidence of an existing arrangement; (b) fixed or determinable price; (c) delivery has occurred or service has been rendered; and (d) collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a) estimate of total hours and milestones to complete; (b) total hours completed; (c) delivery of services rendered; (d) change in estimates; and (e) collectability of the contract.
 
The Company had one major customer including their affiliates which generated approximately 55% of its revenue in the three months ended September 30, 2016.
 
The Company had four major customers including their affiliates which generated approximately 43% (21%, 16%, 15% and 11%) of its revenue in the nine months ended September 30, 2016.
 
At September 30, 2016, the Company had three customers representing 24%, 17% and 15% of the outstanding accounts receivable.
 
Certain Software as a Service (SaaS) and website hosting contracts are prepared and invoiced on an annual basis. Any funds received for hosting services not provided yet are held in deferred revenue, and are recorded as revenue when earned.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock based compensation
 
The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash.
Derivatives, Policy [Policy Text Block]
Derivative Instrument Liability
 
The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At September 30, 2016 and December 31, 2015, the Company did not have any derivative instruments that were designated as hedges.
 
On October 9, 2015, the Company issued convertible promissory notes representing $2,500,000 in aggregate principal together with warrants exercisable for up to 25,000,000 shares of Common Stock. The warrants have a strike price of $0.10 and term of 5 years. In addition on May 9, 2016, in connection with the sale of the Company’s common stock, the Company issued warrants exercisable for up to 1,312,000 shares of Common Stock. The warrants have a strike price of $0.25 and a term of 5 years.
 
In accordance with ASC 815, these outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheets. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the “operating activities” of the Consolidated Statements of Cash Flow. At September 30, 2016 and December 31, 2015, the derivative liability was stated at $3,648,243 and $439,361, respectively. The change in fair value of $2,990,096 was driven by the increased value of the Company’s common stock in the period and recorded as the “Loss on change in derivative liability” in the Consolidated Statements of Operations for the nine months ended September 30, 2016. As the warrants are exercised or expire, the derivative liability will be adjusted on the balance sheet and an adjustment will be reflected in stockholders equity under additional paid-in capital.
Fair Value Measurement, Policy [Policy Text Block]
Fair Value Measurements
 
Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels: 
 
Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.
 
Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.
 
Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.
 
An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.
 
In October and November 2015, the Company issued warrants with an exercise price of $0.10 in connection with a convertible debt instruments. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.10 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.
 
The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.031 to $0.058, volatility was estimated to be 102%, the risk free rate ranged 1.14% to 1.75% and the remaining term was 5 years.
 
In April and May 2016, the Company issued warrants with an exercise price of $0.25 in connection with the sale of Common Stock. The five year warrants also contain a provision that the warrant exercise price will automatically be adjusted for any common stock equity issuances at less than $0.25 per share. The Company determined that the warrants were not afforded equity classification because the warrants are not considered to be indexed to the Company’s own stock due to the anti-dilution provision. Accordingly, the warrants are treated as a derivative liability and are carried at fair value.
 
The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $0.169 to $0.195, volatility was estimated to be from 169% to 178%, the risk free rate ranged 1.22% to 1.35% and the remaining term was 5 years. The estimated initial fair value of these warrants of $218,786 was reclassified from equity to liability at the date of issuance.
 
At September 30, 2016, the price of the Company stock was 0.149, volatility was estimated to be 170.52%, the risk free rate of 1.14% and the remaining term ranged from 4.02 to 4.56 years. As of September 30, 2016, the fair value of the warrants was determined to be $3,648,243, resulting in an unrealized gain (loss) on the change in the fair value of this derivative liability of $351,055 and $(2,990,096) for the three and nine months ended September 30, 2016, respectively.
 
The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of September 30, 2016 and December 31, 2015:
 
 
 
 
 
 
Fair Value
 
 
Fair Value
 
 
Hierarchy
Assets
 
 
 
 
 
 
Marketable securities, September 30, 2016
 
$
3,600
 
 
Level 1
Marketable securities, December 31, 2015
 
$
3,600
 
 
Level 1
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
Derivative Liability , September 30, 2016
 
$
3,648,243
 
 
Level 3
Derivative Liability , December 31, 2015
 
$
439,361
 
 
Level 3
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
 
There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
ORGANIZATION AND BASIS OF PRESENTATION (Tables)
9 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of September 30, 2016 and December 31, 2015:
 
 
 
 
 
 
Fair Value
 
 
Fair Value
 
 
Hierarchy
Assets
 
 
 
 
 
 
Marketable securities, September 30, 2016
 
$
3,600
 
 
Level 1
Marketable securities, December 31, 2015
 
$
3,600
 
 
Level 1
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
Derivative Liability , September 30, 2016
 
$
3,648,243
 
 
Level 3
Derivative Liability , December 31, 2015
 
$
439,361
 
 
Level 3
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
INTANGIBLE ASSETS (Tables)
9 Months Ended
Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Prior to any impairment adjustment, intangible assets consisted of the following:
 
 
 
September 30,
 
 
December 31,
 
 
 
2016
 
 
2015
 
Patents
 
$
3,697,076
 
 
$
3,655,069
 
Capitalized software development
 
 
621,567
 
 
 
621,567
 
Accumulated amortization
 
 
(1,864,481
)
 
 
(1,435,780
)
Intangible assets, net
 
$
2,454,162
 
 
$
2,840,856
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2016
Notes Payable [Abstract]  
Schedule of Debt [Table Text Block]
As of September 30, 2016 and December 31, 2015, the Company has short term and long term notes payable of $24,000 and $5,800, and $24,000 and $1,923,499, respectively as shown in the table below.
 
Notes and loans payable
 
September 30,
2016
 
 
December 31,
2015
 
Short Term
 
 
 
 
 
 
 
 
Maryland TEDCO
 
$
24,000
 
 
$
24,000
 
Total
 
$
24,000
 
 
$
24,000
 
Long Term
 
 
 
 
 
 
 
 
Convertible Secured Note (net of unamortized discounts of $600,301 in 2015)
 
 
-
 
 
 
1,899,699
 
Maryland TEDCO
 
$
5,800
 
 
$
23,800
 
Total
 
$
5,800
 
 
$
1,923,499
 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
OPTIONS (Tables)
9 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
As of September 30, 2016 and December 31, 2015, the Company has outstanding options to purchase 25,005,504 and 14,759,914 shares of common stock, respectively.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intrinsic
 
 
 
 
 
 
 
 
 
Wtd Avg.
 
 
 
 
 
Value
 
 
 
Number of
 
 
Wtd Avg.
 
 
Remaining
 
 
 
 
 
of Exercisable
 
 
 
Options
 
 
Exercise Price
 
 
Term
 
 
Exercisable
 
 
Options
 
Outstanding at December 31, 2015
 
 
14,759,914
 
 
$
0.30
 
 
 
3.61
 
 
 
8,374,294
 
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
10,756,090
 
 
 
0.08
 
 
 
4.86
 
 
 
 
 
 
 
 
Forfeited/Expired
 
 
(510,500
)
 
 
0.78
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at September 30, 2016
 
 
25,005,504
 
 
$
0.20
 
 
 
3.52
 
 
 
13,177,211
 
 
$
417,857
 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
WARRANTS (Tables)
9 Months Ended
Sep. 30, 2016
Warrants [Abstract]  
Schedule of Other Share-based Compensation, Activity [Table Text Block]
Below is a table summarizing the Company’s outstanding warrants as of September 30, 2016 and December 31, 2015:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intrinsic
 
 
 
 
 
 
 
 
 
Wtd Avg.
 
 
 
 
 
Value
 
 
 
Number of
 
 
Wtd Avg.
 
 
Remaining
 
 
 
 
 
of Exercisable
 
 
 
Warrants
 
 
Exercise Price
 
 
Term
 
 
Exercisable
 
 
Warrants
 
Outstanding at December 31, 2015
 
 
42,526,609
 
 
$
0.22
 
 
 
4.15
 
 
 
41,297,920
 
 
$
1,167
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercised
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
21,961,513
 
 
 
0.02
 
 
 
4.66
 
 
 
 
 
 
 
-
 
Expired
 
 
(393,081
)
 
 
0.42
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at September 30, 2016
 
 
64,095,041
 
 
 
0.15
 
 
 
3.73
 
 
 
63,907,541
 
 
$
4,059,950
 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
ORGANIZATION AND BASIS OF PRESENTATION (Details) - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities held in related party $ 3,600 $ 3,600
Derivative Liability, Fair Value, Gross Liability   627,293
Fair Value, Inputs, Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities held in related party 3,600 3,600
Fair Value, Inputs, Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liability, Fair Value, Gross Liability $ 3,648,243 $ 439,361
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Oct. 09, 2015
May 31, 2016
May 31, 2016
Nov. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Apr. 30, 2016
Dec. 31, 2015
Nov. 08, 2015
Summary Of Significant Accounting Policies [Line Items]                      
Common Stock Issuance Price Per Share     $ 0.25 $ 0.10              
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.10 $ 0.25 $ 0.25 $ 0.10         $ 0.001    
Share Price         $ 0.149   $ 0.149        
Fair Value Assumptions, Weighted Average Volatility Rate             170.52%        
Fair Value Assumptions, Risk Free Interest Rate             1.14%        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 5 years   5 years                
Fair Value Adjustment of Warrants     $ 218,786       $ 3,648,243        
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Change in Unrealized Gain (Loss)             2,990,096        
Derivative Liability, Current         $ 3,648,243   3,648,243     $ 439,361  
Unrealized Gain (Loss) on Derivatives         $ 351,055 $ 0 $ (2,990,096) $ 0      
Class Of Warrant Or Right Exercisable Number 25,000,000                    
Debt Instrument, Face Amount $ 2,500,000                   $ 2,500,000
Stock Issued During Period Value Warrants Exercised 1,312,000 1,312,000                  
Black-scholes option pricing model [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Share Price         $ 0.175   $ 0.175        
Fair Value Assumptions, Weighted Average Volatility Rate       102.00%     178.00%        
Fair Value Assumptions, Risk Free Interest Rate             1.24%        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period       5 years     5 years        
Warrant [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Fair Value Assumptions, Weighted Average Volatility Rate 0.25%                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 5 years                    
Minimum [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights         0.038   $ 0.038        
Share Price   $ 0.169 $ 0.169                
Fair Value Assumptions, Weighted Average Volatility Rate     169.00%                
Fair Value Assumptions, Risk Free Interest Rate     1.22%                
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period             4 years 7 days        
Minimum [Member] | Black-scholes option pricing model [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Share Price       $ 0.031              
Fair Value Assumptions, Risk Free Interest Rate       1.14%              
Minimum [Member] | Warrant [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term             1 year 6 months        
Maximum [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights         $ 0.179   $ 0.179        
Share Price   $ 0.195 $ 0.195                
Fair Value Assumptions, Weighted Average Volatility Rate     178.00%                
Fair Value Assumptions, Risk Free Interest Rate     1.35%                
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period             4 years 6 months 22 days        
Maximum [Member] | Black-scholes option pricing model [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Share Price       $ 0.058              
Fair Value Assumptions, Risk Free Interest Rate       1.75%              
Maximum [Member] | Warrant [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term             2 years 6 months        
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Concentration Risk, Percentage         55.00%   43.00%        
Customer One [Member] | Sales Revenue, Net [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Concentration Risk, Percentage             21.00%        
Customer One [Member] | Accounts Receivable [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Concentration Risk, Percentage             24.00%        
Customer Two [Member] | Sales Revenue, Net [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Concentration Risk, Percentage             16.00%        
Customer Two [Member] | Accounts Receivable [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Concentration Risk, Percentage             17.00%        
Customer Three [Member] | Sales Revenue, Net [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Concentration Risk, Percentage             15.00%        
Customer Three [Member] | Accounts Receivable [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Concentration Risk, Percentage             15.00%        
Customer Four [Member] | Sales Revenue, Net [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Concentration Risk, Percentage             11.00%        
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
MANAGEMENT LIQUIDITY PLANS (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
May 31, 2016
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Going Concern And Management Liquidity Plans [Line Items]        
Working Capital Amount   $ 2,742,006    
Company used net cash in operations   (1,711,819) $ (4,804,778)  
Working Capital   906,237    
Cash   $ 1,494,513   $ 1,687,257
Proceeds from Issuance or Sale of Equity $ 1,579,082      
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2016
Dec. 31, 2015
Related Party Transaction [Line Items]      
Related party payables $ 14,744 $ 14,744 $ 153,474
Operating Leases, Rent Expense, Net, Total 1,500 4,500  
Executive Officer [Member]      
Related Party Transaction [Line Items]      
Due to Related Parties 5,992 5,992 72,944
Operating Leases, Rent Expense, Net, Total   500  
Sean Bradley      
Related Party Transaction [Line Items]      
Due to Related Parties $ 8,752 $ 8,752 6,250
David Moradi      
Related Party Transaction [Line Items]      
Due to Related Parties     70,000
Interest Receivable     $ 4,280
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
INTANGIBLE ASSETS (Details) - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Intangible Assets    
Accumulated amortization $ (1,864,481) $ (1,435,780)
Intangible assets, net 2,454,162 2,840,856
Patents    
Intangible Assets    
Finite-Lived Intangible Assets, Gross 3,697,076 3,655,069
Capitalized software development    
Intangible Assets    
Finite-Lived Intangible Assets, Gross $ 621,567 $ 621,567
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
INTANGIBLE ASSETS (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Finite-Lived Intangible Assets [Line Items]        
Amortization of Intangible Assets     $ 428,701 $ 395,617
Software Development Costs        
Finite-Lived Intangible Assets [Line Items]        
Amortization of Intangible Assets $ 56,119 $ 40,427 147,637 126,677
Patents [Member]        
Finite-Lived Intangible Assets [Line Items]        
Amortization of Intangible Assets $ 94,209 $ 87,395 281,064 268,940
Finite-lived Intangible Assets Acquired     $ 42,007 $ 88,156
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
NOTES PAYABLE (Details) - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Notes and loans payable    
Short Term $ 24,000 $ 24,000
Long Term 5,800 1,923,499
Convertible Secured Note (net of unamortized discounts of $600,301 in 2015) 0 1,899,699
Maryland TEDCO Note    
Notes and loans payable    
Short Term 24,000 24,000
Long Term $ 5,800 $ 23,800
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
NOTES PAYABLE (Details Textual) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 09, 2015
May 31, 2016
Apr. 30, 2016
Apr. 18, 2016
Oct. 24, 2011
May 31, 2016
Nov. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Nov. 09, 2015
Nov. 08, 2015
Dec. 31, 2012
Debt Instrument [Line Items]                              
Debt Instrument, Face Amount $ 2,500,000                         $ 2,500,000  
Notes and Loans Payable, Current, Total               $ 24,000   $ 24,000   $ 24,000      
Long-term Debt, Total               $ 5,800   $ 5,800   1,923,499      
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.10 $ 0.25 $ 0.001     $ 0.25 $ 0.10                
Share Price               $ 0.149   $ 0.149          
Fair Value Assumptions, Risk Free Interest Rate                   1.14%          
Proceeds from Notes Payable                       2,500,000      
Derivative Liability, Fair Value, Gross Liability                       627,293      
Amortization of Debt Discount (Premium)               $ 0   $ 600,301 $ 0        
Stock Issued During Period, Shares, New Issues   11,714,285                          
Debt Conversion, Converted Instrument, Amount                   $ 1,078,123 0        
Debt Conversion, Description                   In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the “Purchase Agreement Amendment”) and an Omnibus Amendment to Secured Promissory Notes (the “Note Amendment”), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the “Original Agreement”) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, “Anthion”) to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of “qualified financing” under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing “blocker” provisions (“Special Warrants”) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar “blocker” provisions.          
Gain (Loss) on Extinguishment of Debt               $ 0 $ 0 $ (1,664,281) $ 0        
Fair Value Assumptions, Weighted Average Volatility Rate                   170.52%          
Maximum [Member]                              
Debt Instrument [Line Items]                              
Class of Warrant or Right, Exercise Price of Warrants or Rights               $ 0.179   $ 0.179          
Share Price   $ 0.195       $ 0.195                  
Fair Value Assumptions, Risk Free Interest Rate           1.35%                  
Fair Value Assumptions, Weighted Average Volatility Rate           178.00%                  
Minimum [Member]                              
Debt Instrument [Line Items]                              
Class of Warrant or Right, Exercise Price of Warrants or Rights               0.038   0.038          
Share Price   $ 0.169       $ 0.169                  
Fair Value Assumptions, Risk Free Interest Rate           1.22%                  
Fair Value Assumptions, Weighted Average Volatility Rate           169.00%                  
Black-scholes option pricing model [Member]                              
Debt Instrument [Line Items]                              
Share Price               0.175   $ 0.175          
Fair Value Assumptions, Expected Term                   5 years          
Fair Value Assumptions, Risk Free Interest Rate                   1.24%          
Fair Value Assumptions, Weighted Average Volatility Rate             102.00%     178.00%          
Black-scholes option pricing model [Member] | Maximum [Member]                              
Debt Instrument [Line Items]                              
Share Price             $ 0.058                
Fair Value Assumptions, Risk Free Interest Rate             1.75%                
Black-scholes option pricing model [Member] | Minimum [Member]                              
Debt Instrument [Line Items]                              
Share Price             $ 0.031                
Fair Value Assumptions, Risk Free Interest Rate             1.14%                
Amendments to Existing Agreements [Member]                              
Debt Instrument [Line Items]                              
Interest Payable, Current       $ 119,801                      
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 0.001                      
Stock Issued During Period, Shares, New Issues       12,834,800                      
Warrants Issued During Period, Shares       18,353,310                      
Debt Conversion, Converted Instrument, Amount       $ 2,500,000                      
Note and Warrant Purchase Agreement [Member]                              
Debt Instrument [Line Items]                              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 37,500,000                            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 10.00%                            
Convertible Notes Payable [Member]                              
Debt Instrument [Line Items]                              
Debt Conversion, Original Debt, Amount                   $ 1,025,000          
Debt Instrument, Convertible, Conversion Price               $ 0.84   $ 0.84          
Warrants and Rights Outstanding               $ 3,205,959   $ 3,205,959          
Debt Instrument, Convertible, If-converted Value in Excess of Principal     $ 1,541,678             1,541,678          
Gain (Loss) on Extinguishment of Debt                   1,664,281          
Loans Payable                              
Debt Instrument [Line Items]                              
Long-term Debt, Gross                             $ 74,900
Debt Instrument, Interest Rate, Stated Percentage                             25.00%
Interest Payable, Current                             $ 74,900
Maryland TEDCO Note                              
Debt Instrument [Line Items]                              
Debt Instrument, Periodic Payment, Total         $ 2,000                    
Long-term Debt, Gross               29,800   29,800   47,800      
Debt Instrument, Face Amount         $ 149,800                    
Notes and Loans Payable, Current, Total               24,000   24,000   24,000      
Long-term Debt, Total               $ 5,800   5,800   $ 23,800      
Repayments of Long-term Debt, Total                   $ 18,000          
Notes                              
Debt Instrument [Line Items]                              
Debt Instrument, Face Amount $ 3,750,000                       $ 2,500,000    
Debt Conversion Total Issued And Outstanding Common Shares Percent 60.00%                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 25,000,000                            
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.10                            
Proceeds from Sale of Available-for-sale Securities, Equity $ 1,000,000                            
Notes | Maximum [Member]                              
Debt Instrument [Line Items]                              
Proceeds from Sale of Available-for-sale Securities, Equity 2,000,000                            
Notes | Minimum [Member]                              
Debt Instrument [Line Items]                              
Proceeds from Sale of Available-for-sale Securities, Equity $ 1,000,000                            
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
STOCKHOLDERS' EQUITY (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Oct. 15, 2015
Oct. 09, 2015
Sep. 30, 2016
Aug. 31, 2016
Jul. 31, 2016
May 31, 2016
Apr. 30, 2016
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Nov. 30, 2015
Class of Stock [Line Items]                      
Common Stock, Shares, Outstanding     107,458,430         107,458,430   81,717,154  
Proceeds from Issuance of Warrants           $ 1,579,082   $ 0 $ 43,943    
Stock Issued During Period, Shares, Issued for Services 41,666   41,666 41,666 124,998   83,336        
Stock Issued During Period Value Warrants Exercised   1,312,000       1,312,000          
Stock Issued During Period, Value, Issued for Services $ 4,292   $ 6,292 $ 6,208 $ 20,666   $ 14,292 $ 47,458      
Stock Issued During Period, Shares, New Issues           11,714,285          
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.10       $ 0.25 $ 0.001       $ 0.10
Class of Warrant or Right, Outstanding     18,353,310       18,353,310 18,353,310      
Preferred Stock, Shares Issued     160,000         160,000   175,000  
Preferred Stock, Shares Outstanding     160,000         160,000   175,000  
Preferred Stock, Par or Stated Value Per Share     $ 0.00001         $ 0.00001   $ 0.00001  
Stock Issued During Period, Shares, Conversion of Convertible Securities             12,834,800        
Stock Issued During Period, Value, Conversion of Convertible Securities             $ 1,025,000 $ 1,078,123      
Class of Warrant or Right, Expiration Term           5 years          
Series A Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred Stock, Dividend Rate, Percentage               5.00%      
Preferred Stock, Shares Issued     160,000         160,000      
Preferred Stock, Shares Outstanding                   175,000  
Preferred Stock, Par or Stated Value Per Share     $ 10         $ 10      
Preferred Stock, Redemption Price Per Share     $ 0.1754         $ 0.1754      
Stock Issued During Period Shares, Conversion Of Preferred Stock           900,525          
Conversion of Stock, Shares Converted           15,000          
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
OPTIONS (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Granted Weighted Average Remaining Term 4 years 7 months 28 days  
Employee Stock Option    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding    
Outstanding at beginning of the period (in shares) 14,759,914  
Granted (in shares) 10,756,090  
Forfeited (in shares) (510,500)  
Outstanding at the end of the period (in shares) 25,005,504 14,759,914
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price    
Outstanding at beginning of the period (in dollars per share) $ 0.30  
Granted (in dollars per share) 0.08  
Forfeited (in dollars per share) 0.78  
Outstanding at end of the period (in dollars per share) $ 0.20 $ 0.30
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding, Weighted Average Remaining Term 3 years 6 months 7 days 3 years 7 months 10 days
Granted Weighted Average Remaining Term 4 years 10 months 10 days  
Exercisable (in shares) 13,177,211 8,374,294
Share Based Compensation Arrangement by Share Based Payment Award Options, Intrinsic Value    
Granted, Intrinsic Value of Exercisable Options $ 0  
Forfeited, Intrinsic Value of Exercisable Options $ 0  
Aggregate Intrinsic Value, Outstanding $ 417,857 $ 0
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
OPTIONS (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 15, 2016
May 12, 2016
Jan. 15, 2016
Apr. 15, 2016
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
May 31, 2016
Apr. 30, 2016
Dec. 31, 2015
Nov. 30, 2015
Oct. 09, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights     Vesting shall only occur if the closing share price of the Companys common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition)                    
Class of Warrant or Right, Exercise Price of Warrants or Rights                 $ 0.25 $ 0.001   $ 0.10 $ 0.10
Maximum                          
Class of Warrant or Right, Exercise Price of Warrants or Rights         $ 0.179   $ 0.179            
Minimum                          
Class of Warrant or Right, Exercise Price of Warrants or Rights         $ 0.038   0.038            
Options                          
Granted (in dollars per share)             $ 0.08            
Share based compensation expense         $ 166,111 $ (119,224) $ 706,230 $ 709,311          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance         25,005,504   25,005,504       14,759,914    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             10,756,090            
Performance Options [Member]                          
Granted (in dollars per share)     $ 0.038                    
Expected term     5 years                    
Expected volatility (as a percent)     162.00%                    
Risk-free interest rate (as a percent)     1.46%                    
Expected dividend yield (as a percent)     0.00%                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     6,500,000                    
Performance Options [Member] | Performance and Market Conditions [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     5,500,000                    
Non Performance Options [Member]                          
Expected dividend yield (as a percent)             0.00%            
Non Performance Options [Member] | Maximum                          
Expected term             3 years 6 months            
Expected volatility (as a percent)             174.99%            
Risk-free interest rate (as a percent)             1.73%            
Non Performance Options [Member] | Minimum                          
Expected term             1 year 6 months            
Expected volatility (as a percent)             102.00%            
Risk-free interest rate (as a percent)             0.87%            
Options Granted On May 2016 One [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   100,000                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date   May 12, 2021                      
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value   $ 16,694                      
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.177                      
Options Granted On May 2016 One [Member] | Share-based Compensation Award, Tranche One [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage   50.00%                      
Options Granted On May 2016 One [Member] | Share-based Compensation Award, Tranche Two [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage   4.17%                      
Options Granted On April 2016 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       49,715                  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price       $ 0.179                  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date       Apr. 15, 2019                  
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value       $ 6,250                  
Options Granted On May 2016 Two [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   3,400,000                      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price   $ 0.177                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date   May 12, 2021                      
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value   $ 559,603                      
Options Granted On May 2016 Two [Member] | Share-based Compensation Award, Tranche One [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage   50.00%                      
Options Granted On May 2016 Two [Member] | Share-based Compensation Award, Tranche Two [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage   50.00%                      
Options Granted On July 2016 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 56,375                        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 0.156                        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Jul. 15, 2019                        
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value $ 6,250                        
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
WARRANTS (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Number of warrants    
Number of shares, beginning 42,526,609  
Number of shares, exercised 0  
Number of shares, granted 21,961,513  
Number of shares,Expired (393,081)  
Number of shares, ending 64,095,041 42,526,609
Weighted average exercise price    
Weighted average exercise price, beginning (in dollars per share) $ 0.22  
Weighted average exercise price, granted (in dollars per share) | $ / shares 0.02  
Weighted average exercise price, Expired (in dollars per share) 0.42  
Weighted average exercise price, ending (in dollars per share) $ 0.15 $ 0.22
Weighted Average Remaining Term    
Wtd Avg. Remaining Term 3 years 8 months 23 days 4 years 1 month 24 days
Wtd Avg. Remaining Term, granted 4 years 7 months 28 days  
Exercisable    
Exercisable (in shares) 63,907,541 41,297,920
Intrinsic Value    
Intrinsic Value, granted   $ 0
Aggregate Intrinsic Value, Outstanding $ 4,059,950 $ 1,167
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
WARRANTS (Details Textual) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Oct. 09, 2015
May 31, 2016
Apr. 30, 2016
May 31, 2016
Nov. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Number of warrants                  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.10 $ 0.25 $ 0.001 $ 0.25 $ 0.10        
Class of Warrant or Right, Outstanding     18,353,310     18,353,310   18,353,310  
Gain (Loss) on Extinguishment of Debt           $ 0 $ 0 $ (1,664,281) $ 0
Share Price           $ 0.149   $ 0.149  
Fair Value Assumptions, Weighted Average Volatility Rate               170.52%  
Fair Value Assumptions, Risk Free Interest Rate               1.14%  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 5 years     5 years          
Share-based Compensation, Total               $ 913,002 1,200,459
Stock Issued During Period Value Warrants Exercised 1,312,000 1,312,000              
Convertible Notes Payable [Member]                  
Number of warrants                  
Class of Warrant or Right, Outstanding           18,353,311   18,353,311  
Debt Instrument, Convertible, If-converted Value in Excess of Principal     $ 1,541,678         $ 1,541,678  
Warrants and Rights Outstanding           $ 3,205,959   3,205,959  
Gain (Loss) on Extinguishment of Debt               $ 1,664,281  
Black-scholes option pricing model [Member]                  
Number of warrants                  
Share Price           $ 0.175   $ 0.175  
Fair Value Assumptions, Weighted Average Volatility Rate         102.00%     178.00%  
Fair Value Assumptions, Risk Free Interest Rate               1.24%  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period         5 years     5 years  
Minimum                  
Number of warrants                  
Class of Warrant or Right, Exercise Price of Warrants or Rights           0.038   $ 0.038  
Share Price   $ 0.169   $ 0.169          
Fair Value Assumptions, Weighted Average Volatility Rate       169.00%          
Fair Value Assumptions, Risk Free Interest Rate       1.22%          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period               4 years 7 days  
Minimum | Black-scholes option pricing model [Member]                  
Number of warrants                  
Share Price         $ 0.031        
Fair Value Assumptions, Risk Free Interest Rate         1.14%        
Maximum                  
Number of warrants                  
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 0.179   $ 0.179  
Share Price   $ 0.195   $ 0.195          
Fair Value Assumptions, Weighted Average Volatility Rate       178.00%          
Fair Value Assumptions, Risk Free Interest Rate       1.35%          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period               4 years 6 months 22 days  
Maximum | Black-scholes option pricing model [Member]                  
Number of warrants                  
Share Price         $ 0.058        
Fair Value Assumptions, Risk Free Interest Rate         1.75%        
Warrants                  
Number of warrants                  
Expected term 5 years                
Unamortized Share based compensation expense           $ 150,500   $ 150,500  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum               166.74%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum               178.98%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum               0.71%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum               1.08%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate               0.00%  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           1,575,954   1,575,954  
Fair Value Assumptions, Weighted Average Volatility Rate 0.25%                
Share-based Compensation, Total           $ 58,599 $ 206,772 $ 20,962 $ 491,148
Warrants | Minimum                  
Number of warrants                  
Expected term               1 year 6 months  
Warrants | Maximum                  
Number of warrants                  
Expected term               2 years 6 months  
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
COMMITMENTS AND CONTINGENCIES (Details Textual)
1 Months Ended
Jul. 25, 2016
USD ($)
Commitments And Contingencies [Line Items]  
Litigation Settlement, Amount $ 1,525,000
Payments for Legal Settlements $ 100,000
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2
SUBSEQUENT EVENTS (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Oct. 15, 2016
Oct. 15, 2015
Sep. 30, 2016
Aug. 31, 2016
Jul. 31, 2016
Apr. 30, 2016
Sep. 30, 2016
Subsequent Event [Line Items]              
Stock Issued During Period, Value, Issued for Services   $ 4,292 $ 6,292 $ 6,208 $ 20,666 $ 14,292 $ 47,458
Stock Issued During Period, Shares, Issued for Services   41,666 41,666 41,666 124,998 83,336  
Sean Bradley [Member]              
Subsequent Event [Line Items]              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 61,599            
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 0.125            
Stock Compensation Plan [Member]              
Subsequent Event [Line Items]              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 3 years            
EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end

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end XML 50 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 143 215 1 false 43 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.audioeyeinc.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.audioeyeinc.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.audioeyeinc.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.audioeyeinc.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 105 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://www.audioeyeinc.com/role/ConsolidatedStatementOfStockholdersEquity CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 106 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.audioeyeinc.com/role/ConsolidatedStatementOfStockholdersEquityParenthetical CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 6 false false R7.htm 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.audioeyeinc.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 108 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION Sheet http://www.audioeyeinc.com/role/OrganizationAndBasisOfPresentation ORGANIZATION AND BASIS OF PRESENTATION Notes 8 false false R9.htm 109 - Disclosure - MANAGEMENT LIQUIDITY PLANS Sheet http://www.audioeyeinc.com/role/ManagementLiquidityPlans MANAGEMENT LIQUIDITY PLANS Notes 9 false false R10.htm 110 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.audioeyeinc.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 10 false false R11.htm 111 - Disclosure - INTANGIBLE ASSETS Sheet http://www.audioeyeinc.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 11 false false R12.htm 112 - Disclosure - NOTES PAYABLE Notes http://www.audioeyeinc.com/role/NotesPayable NOTES PAYABLE Notes 12 false false R13.htm 113 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.audioeyeinc.com/role/StockholdersEquity STOCKHOLDERS' EQUITY Notes 13 false false R14.htm 114 - Disclosure - OPTIONS Sheet http://www.audioeyeinc.com/role/Options OPTIONS Notes 14 false false R15.htm 115 - Disclosure - WARRANTS Sheet http://www.audioeyeinc.com/role/Warrants WARRANTS Notes 15 false false R16.htm 116 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.audioeyeinc.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 117 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.audioeyeinc.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 118 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Policies) Sheet http://www.audioeyeinc.com/role/OrganizationAndBasisOfPresentationPolicies ORGANIZATION AND BASIS OF PRESENTATION (Policies) Policies 18 false false R19.htm 119 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Tables) Sheet http://www.audioeyeinc.com/role/OrganizationAndBasisOfPresentationTables ORGANIZATION AND BASIS OF PRESENTATION (Tables) Tables http://www.audioeyeinc.com/role/OrganizationAndBasisOfPresentation 19 false false R20.htm 120 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://www.audioeyeinc.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://www.audioeyeinc.com/role/IntangibleAssets 20 false false R21.htm 121 - Disclosure - NOTES PAYABLE (Tables) Notes http://www.audioeyeinc.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://www.audioeyeinc.com/role/NotesPayable 21 false false R22.htm 122 - Disclosure - OPTIONS (Tables) Sheet http://www.audioeyeinc.com/role/OptionsTables OPTIONS (Tables) Tables http://www.audioeyeinc.com/role/Options 22 false false R23.htm 123 - Disclosure - WARRANTS (Tables) Sheet http://www.audioeyeinc.com/role/WarrantsTables WARRANTS (Tables) Tables http://www.audioeyeinc.com/role/Warrants 23 false false R24.htm 124 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details) Sheet http://www.audioeyeinc.com/role/OrganizationAndBasisOfPresentationDetails ORGANIZATION AND BASIS OF PRESENTATION (Details) Details http://www.audioeyeinc.com/role/OrganizationAndBasisOfPresentationTables 24 false false R25.htm 125 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) Sheet http://www.audioeyeinc.com/role/OrganizationAndBasisOfPresentationDetailsTextual ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) Details http://www.audioeyeinc.com/role/OrganizationAndBasisOfPresentationTables 25 false false R26.htm 126 - Disclosure - MANAGEMENT LIQUIDITY PLANS (Details Textual) Sheet http://www.audioeyeinc.com/role/ManagementLiquidityPlansDetailsTextual MANAGEMENT LIQUIDITY PLANS (Details Textual) Details http://www.audioeyeinc.com/role/ManagementLiquidityPlans 26 false false R27.htm 127 - Disclosure - RELATED PARTY TRANSACTIONS (Details Textual) Sheet http://www.audioeyeinc.com/role/RelatedPartyTransactionsDetailsTextual RELATED PARTY TRANSACTIONS (Details Textual) Details http://www.audioeyeinc.com/role/RelatedPartyTransactions 27 false false R28.htm 128 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://www.audioeyeinc.com/role/IntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://www.audioeyeinc.com/role/IntangibleAssetsTables 28 false false R29.htm 129 - Disclosure - INTANGIBLE ASSETS (Details Textual) Sheet http://www.audioeyeinc.com/role/IntangibleAssetsDetailsTextual INTANGIBLE ASSETS (Details Textual) Details http://www.audioeyeinc.com/role/IntangibleAssetsTables 29 false false R30.htm 130 - Disclosure - NOTES PAYABLE (Details) Notes http://www.audioeyeinc.com/role/NotesPayableDetails NOTES PAYABLE (Details) Details http://www.audioeyeinc.com/role/NotesPayableTables 30 false false R31.htm 131 - Disclosure - NOTES PAYABLE (Details Textual) Notes http://www.audioeyeinc.com/role/NotesPayableDetailsTextual NOTES PAYABLE (Details Textual) Details http://www.audioeyeinc.com/role/NotesPayableTables 31 false false R32.htm 132 - Disclosure - STOCKHOLDERS' EQUITY (Details Textual) Sheet http://www.audioeyeinc.com/role/StockholdersEquityDetailsTextual STOCKHOLDERS' EQUITY (Details Textual) Details http://www.audioeyeinc.com/role/StockholdersEquity 32 false false R33.htm 133 - Disclosure - OPTIONS (Details) Sheet http://www.audioeyeinc.com/role/OptionsDetails OPTIONS (Details) Details http://www.audioeyeinc.com/role/OptionsTables 33 false false R34.htm 134 - Disclosure - OPTIONS (Details Textual) Sheet http://www.audioeyeinc.com/role/OptionsDetailsTextual OPTIONS (Details Textual) Details http://www.audioeyeinc.com/role/OptionsTables 34 false false R35.htm 135 - Disclosure - WARRANTS (Details) Sheet http://www.audioeyeinc.com/role/WarrantsDetails WARRANTS (Details) Details http://www.audioeyeinc.com/role/WarrantsTables 35 false false R36.htm 136 - Disclosure - WARRANTS (Details Textual) Sheet http://www.audioeyeinc.com/role/WarrantsDetailsTextual WARRANTS (Details Textual) Details http://www.audioeyeinc.com/role/WarrantsTables 36 false false R37.htm 137 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Textual) Sheet http://www.audioeyeinc.com/role/CommitmentsAndContingenciesDetailsTextual COMMITMENTS AND CONTINGENCIES (Details Textual) Details http://www.audioeyeinc.com/role/CommitmentsAndContingencies 37 false false R38.htm 138 - Disclosure - SUBSEQUENT EVENTS (Details Textual) Sheet http://www.audioeyeinc.com/role/SubsequentEventsDetailsTextual SUBSEQUENT EVENTS (Details Textual) Details http://www.audioeyeinc.com/role/SubsequentEvents 38 false false All Reports Book All Reports aeye-20160930.xml aeye-20160930.xsd aeye-20160930_cal.xml aeye-20160930_def.xml aeye-20160930_lab.xml aeye-20160930_pre.xml true true ZIP 55 0001144204-16-134226-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-16-134226-xbrl.zip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